Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Aug 1.
Published in final edited form as: Neurosci Biobehav Rev. 2025 May 21;175:106217. doi: 10.1016/j.neubiorev.2025.106217

Mechanistic and translational insights from preclinical cocaine choice procedures on the economic substitutability of cocaine and nondrug reinforcers

Madison M Marcus 1,2,3,*, Matthew L Banks 3
PMCID: PMC12268939  NIHMSID: NIHMS2085280  PMID: 40409443

Abstract

Substance use disorders are increasingly being conceptualized as behavioral misallocation disorders; however, the neurobiological determinants of this behavioral misallocation are poorly understood. Cocaine use disorder (CUD) develops as a result of behavior being disproportionally directed towards the procurement and use of cocaine at the expense of behaviors maintained by more adaptive, nondrug reinforcers (i.e., job, family). Preclinical cocaine-vs-nondrug reinforcer choice procedures are uniquely positioned to 1) elucidate the biological mechanisms of drug and nondrug reinforcement and 2) inform the development of effective pharmacological and behavioral CUD therapies. Accordingly, this review addresses the existing preclinical literature regarding the economic substitutability and mesolimbic dopaminergic mechanisms underlying cocaine self-administration in the context of three different concurrently available nondrug reinforcers: food, social interaction, and electric foot shock (a negative reinforcer). The manuscript focuses on how the existing cocaine-vs-nondrug reinforcer choice literature guides future research directions to facilitate advances in understanding of CUD from both a neuroscience and translational research perspective.

Keywords: Substance use disorder, cocaine, drug choice, behavioral economics, social interaction, negative reinforcement, dopamine

1. Introduction

Cocaine is an illicit substance that continues to impose significant public health issues. Over 50 million individuals over the age of 12 have used cocaine within their lifetime and 1.4 million people met DSM-5 criteria for cocaine use disorder (CUD) in 2021 (National Survey on Drug Use and Health, 2021). Furthermore, cocaine-related deaths have increased every year since 2010 (Jones et al., 2017; Kampman, 2019; Lipari and Park-Lee, 2020) and have exponentially risen from 2016 to 2021 (National Institute on Drug Abuse, 2023), earning stimulant use disorder the title of the “twin” or “silent” epidemic related to the current opioid crisis (Fischer et al., 2021). Unlike opioid use disorder, for which there are currently three Food and Drug Administration-approved pharmacotherapies (i.e., naltrexone, buprenorphine, and methadone), there are currently zero widespread treatment options for CUD.

The overarching goal of this review is to examine how the existing cocaine-vs-nondrug reinforcer choice literature informs future CUD treatment efforts from both a neuroscience and translational research perspective. We begin by describing the existing cocaine-vs-nondrug reinforcer choice literature focusing on the degree of economic substitutability of cocaine and three different nondrug reinforcers: food, social interaction, and foot shock (as a negative reinforcer). The current knowledge on the temporal dynamics of mesolimbic dopamine (DA) signaling that may underlie the behavioral economic relationship between cocaine and each nondrug reinforcer will be discussed, as these temporal dynamics may provide mechanistic insights regarding how subjects choose between drug and nondrug reinforcement options when concurrently available. We will focus on outlining the additional information gleaned by integrating in vivo neurochemical biosensor technology with the sophisticated cocaine-vs-nondrug self-administration procedures. Finally, each section will discuss how investigating these neurobiological and behavioral mechanisms of cocaine choice provide new research directions in the development of pharmacological and behavioral treatments for individuals with CUD.

2. Background

a. Substance use disorder is a behavioral allocation disorder

Over half of the DSM-5 diagnostic criteria are associated with a distinct behavioral pattern in which an individual with SUD will allocate the majority of their behavior towards procuring and using the drug and consequently, engagement with more adaptive, nondrug reinforcers may be reciprocally reduced. As such, SUD is increasingly being conceptualized as a behavioral allocation disorder (Acuff et al., 2024b; Banks and Negus, 2017a; Heyman, 2009; Lamb and Ginsburg, 2018). Figure 1 illustrates this conceptual framework. An individual without SUD allocates most of their behavior amongst nondrug reinforcers (e.g., social interaction, money, health) and therefore allocates little to no behavior towards commonly misused drugs (Panel A). On the other hand, an individual with SUD may fail to engage or reduce engagement with family or employment and reallocate a maladaptive amount of their behavior towards drug use (Panel B). One contemporary theory suggests this behavioral misallocation in individuals with SUD is driven by decision-making processes focused on maximizing local or immediate satisfaction, as opposed to global or long-term satisfaction (Heyman, 2009; Rachlin, 1997). In alignment with this conceptual framework, an effective SUD treatment would encourage individuals to consider and make decisions that resulted in maximizing global satisfaction. This shift in perspective would result in individuals reducing drug-taking behavior and increasing engagement with nondrug reinforcers.

Figure 1.

Figure 1.

In the natural environment, there are several non-drug positive reinforcers available. Examples are social interaction, money, food, sleep, or exercise. An individual without SUD (Panel A) will allocate their behavior amongst these reinforcers (wide arrows) and consequently engage in little to no drug-taking behavior (dashed arrow). In contrast, an individual with SUD (Panel B) exhibits a maladaptive allocation of behavior in which most behavior is allocated towards taking and procuring commonly misused drugs (wide arrow). Consequently, less behavior is allocated towards engaging with non-drug reinforcers (dashed arrows). An effective treatment for SUD would shift behavioral allocation to non-drug reinforcers (Panel A). Adapted from Banks and Negus 2017. Created with BioRender.

b. Drug-vs-nondrug reinforcer choice procedures

Preclinical drug-vs-nondrug reinforcer choice procedures provide a simplified model of this concurrent reinforcer availability clinical context. In a typical preclinical drug choice procedure, monkeys or rats have concurrent access to a drug reinforcer (e.g., cocaine) and a nondrug positive reinforcer (e.g., food). Presentation of either reinforcer follows the three-term contingency (Skinner, 1953) that forms the basis of all operant conditioning (Box 1). For instance, in the rodent cocaine-vs-food choice procedure illustrated in Figure 2, the illumination of a tricolor stimulus light (the SD1) indicates that pressing the cocaine-associated response lever (R1) will result in the delivery of an intravenous (IV) cocaine injection (the SC1). A second, food-associated, yellow stimulus light (SD2) is also presented, indicating that completing the response requirement on the food-associated response lever (R2) will result in presentation of a food reinforcer (the SC2). Thus, the rat is given the opportunity to allocate its behavior or “choose” between these two available reinforcers of cocaine and food. The primary dependent measures are 1) behavior maintained by the cocaine reinforcer 2) behavior maintained by the food reinforcer, and 3) the proportion of behavior allocated towards cocaine choice.

Box 1. Operant conditioning theory, established by Skinner (1953), explains how behaviors are learned and influenced by their consequences according to a three-term contingency:

SD→R→SC

A discriminative stimulus (SD) is an aspect of an organism’s environment that signals an operant contingency is in place and a consequent stimulus (SC) is available. Reinforcement contingencies increase the likelihood of a subject emitting the response (R) through either presentation (positive reinforcement) or removal (negative reinforcement) of SC. Punishment contingencies on the other hand decrease the likelihood of a subject emitting the response (R) through either presentation (positive punishment) or removal (negative punishment) of the SC.

Commonly misused drugs function as positive reinforcers. Individuals learn discriminative stimuli (SD) associated with drug availability (e.g., drug paraphernalia), engage in drug-taking behavior (R), and consequently experience drug intoxication (SC). If drug intoxication is reinforcing, then intoxication increases the likelihood that they will engage in drug-taking behavior again. Human and preclinical drug self-administration experiments utilize the three-term contingency with the drug delivery as the SC and therefore can be readily used to study the function of commonly misused drugs as reinforcing stimuli. Humans, monkeys, and rats will self-administer commonly misused drugs, indicating the translational utility of preclinical self-administration procedures (see Table 1).

One contemporary theory is that drug-taking behavior is motivated not by the positive reinforcing effects of the drug, but by the removal of an endogenous aversive withdrawal state (negative reinforcement) (Koob, 2020). In this interpretation, the withdrawal state would be the negative reinforcer whose removal by the self-administered drug infusion increases drug-taking behavior. However, the empirical evidence does not support a robust role for cocaine withdrawal as a negative reinforcer driving cocaine self-administration (Negus and Banks, 2018) and recent studies suggest that opioid withdrawal may also function as a relatively weak negative reinforcer (Marcus et al., 2024).]

Figure 2.

Figure 2.

Identification of stimuli and response options in a rodent concurrent cocaine-vs-food choice procedure. The rat is free to allocate behavior between these two concurrently available reinforcers, depending upon the programmed experimental parameters. SD: discriminative stimulus; R: Response; SC: consequent stimulus. Created with BioRender.

Two fundamental independent variables that have been manipulated to assess the behavioral economics of commodities within drug-vs-alternative nondrug reinforcer choice procedures are reinforcer magnitude and response requirement. The reinforcer magnitude or “strength” of a reinforcer can be altered by changing reinforcer size, amount, duration, or intensity. For example, increasing the magnitude of a drug reinforcer is conventionally done by increasing the intravenous drug dose that the rat receives (SC). Methods to alter the reinforcing magnitude of various nondrug reinforcers (food, social interaction, and a negative reinforcer) will be discussed in the following sections. Another set of independent variables that can be manipulated in an experimental choice context is response requirement or “cost.” In laboratory studies, altering response requirement often refers to changing the number of operant responses (R) the subject is required to emit to be presented with the consequent stimulus (SC). When a fixed number of operant responses are required for reinforcer presentation, this is called a fixed-ratio (FR) schedule of reinforcement (Skinner, 1938). Increasing the response requirement for a reinforcer could be achieved by changing the schedule of reinforcement from FR1 (i.e., one lever press results in a cocaine infusion) to FR30 (i.e., 30 lever presses result in a cocaine infusion).

Historically, preclinical drug self-administration research has been conducted under single operant experimental conditions, such that only the commonly misused drug was available as a SC in the environment. As discussed in published reviews (Banks et al., 2019; Banks and Negus, 2012; Negus and Banks, 2021), the use of drug choice procedures to study the mechanisms of and treatments for drug self-administration offers many advantages over the use of traditional single operant drug self-administration procedures. Briefly, preclinical choice procedures have been shown to facilitate translation of animal-to-human results (Ahmed et al., 2013; Foltin et al., 2015; Johnson et al., 2016; Lile et al., 2016; Negus and Banks, 2020, 2021). Additionally, substance use disorder treatment should not only reduce drug-taking behavior but also promote a reallocation of behavior to nondrug reinforcers. Preclinical choice procedures provide a simplified context to measure this desired therapeutic-like effect.

c. Effective behavioral treatments for CUD are founded on scientific principles of operant conditioning and behavioral economics

Contingency management is a behavior-focused treatment strategy for CUD that facilitates the therapeutic outcome of behavioral reallocation to nondrug reinforcers using the scientific principles of operant conditioning and behavioral economics. In fact, a 2021 meta-analysis found contingency management to be the only treatment significantly associated with an increased likelihood of cocaine abstinence in individuals with CUD (Bentzley et al., 2021). Contingency management programs focus on reducing engagement with the three-term drug reinforcement contingency (Box 1) by introducing a competing nondrug reinforcement contingency. In conventional contingency management programs, individuals are presented a monetary nondrug positive reinforcer in exchange for a drug-free urine sample. Thus, contingency management programs establish conditions where there are two mutually exclusive reinforcement contingencies concurrently available to the individual: use the drug and experience intoxication or remain drug abstinent and receive a monetary reinforcer.

Contingency management programs are founded in the economic principles of demand, which state that two available commodities or reinforcers can interact as substitutes, complements, or independents. Economic substitutes are two commodities (e.g., Coca-Cola and Pepsi) where only one or the other is chosen. Changes in the price or availability of Coca-Cola affects consumption of both Coca-Cola and Pepsi, but in opposite directions. Alternatively, commodities could function as economic complements if they are consumed together, where the changes in the price or availability of hotdog buns affects consumption of both hotdog buns and hotdogs in the same direction. Finally, independent commodities are two commodities that are not related. Changes in the price or availability of textbooks does not change consumption of baby diapers. Economic independents, complements, and substitutes are not three discrete categories. Rather, these terms exist along a continuum with perfect substitutes at one end, perfect complements at the other, and independents in the middle.

An important requirement of contingency management is that the nondrug reinforcer functions as an economic substitute for the commonly misused drug reinforcer. Therefore, increases in availability or accessibility of the nondrug reinforcer should decrease engagement with the drug reinforcer. For example, traditional contingency management programs utilize money as the nondrug reinforcer. Money is a token that can be exchanged for any number of commodities, making it a good economic substitute for almost any positive reinforcer, including commonly misused substances. Although money is effective in reducing drug-taking behavior in this contingency management context, adoption of monetary-based contingency management remains limited (Petry et al., 2017), and this highlights an opportunity to identify other nondrug reinforcers that function as economic substitutes for drug-taking. Identification of other economic substitutes could improve contingency management and inform the development of novel, effective behavioral therapies for individuals with SUD. Further, if two commodities function as economic substitutes, this may suggest a more similar biological mechanism of reinforcement than two commodities that function as economic independents or complements.

d. Studying the temporal dynamics of mesolimbic DA signaling may reveal mechanistic insights on cocaine and nondrug reinforcement processes

The primary pharmacological mechanism of cocaine reinforcement is NAc dopamine transporter inhibition, resulting in increased synaptic NAc DA levels. Thus, studies have begun to examine the temporal dynamics of NAc DA during cocaine self-administration. One FSCV study found that when rats self-administer cocaine IV, NAc DA rises prior to the lever press (R), reaching peak concentration between 1 and 2 s post-lever press, and then declines over the next 10 s (Cameron et al., 2014). Similarly, a mouse fiber photometry study indicated that NAc DA peaked within 5 s of the operant response (R) for cocaine (Luján et al., 2023). However, studies have yet to determine precise changes in the NAc DA signal relative to the presentation of the cocaine discriminative stimulus (SD), and during the cocaine infusion (SC). One future direction would be to combine FSCV or fiber photometry with operant cocaine self-administration to improve our fundamental knowledge regarding how the mesolimbic DA system is activated during each one of these key steps in the three-term contingency.

Similar to cocaine, there is evidence to suggest that the underlying neurobiological mechanism of reinforcement for each of the three nondrug reinforcers described in the following sections (food, social interaction, and negative reinforcement) also involves mesolimbic DA pathway activation. However, the temporal dynamics of this mesolimbic DA signaling may slightly differ between cocaine and these nondrug reinforcers. Each of the following sections will describe the current knowledge on the temporal dynamics of DA signaling in food, social, and negative reinforcement. This discussion will emphasize areas for future research towards understanding neurobiological underpinnings to predict if two reinforcers will function as economic substitutes, independents, or complements. Our knowledge of how mesolimbic DA signaling is altered when two reinforcers are available remains unknown as literature has focused on the role of DA neurotransmission during either single reinforcer availability or non-operant procedures. Thus, there are critical gaps in our knowledge as to how mesolimbic DA signaling functions when two reinforcers are concurrently available.

3. Cocaine-vs-food choice

The rich literature on cocaine-vs-food choice provides insight on the economic substitutability of cocaine and food reinforcers. Cocaine-vs-food choice studies in both rats and monkeys (Table 1) have shown that cocaine-vs-food choice is related to the magnitude of the cocaine reinforcer (i.e., cocaine dose), whereby there is a dose-dependent increase in cocaine choice (although see Lenoir et al., 2007). As an example, when the choice is between a small cocaine dose and a food reinforcer, subjects allocate their behavior towards food. When given the choice between a large cocaine dose and a food reinforcer, subjects allocate their behavior towards cocaine (Figure 3, black line).

Table 1.

Summary of papers contributing to the current cocaine-vs-non-drug reinforcer choice literature. Studies included in this table were identified based on an extensive PubMed search for nonhuman and human studies that systematically manipulated one of the independent variables in the first column in a cocaine-vs-non-drug reinforcer (money, food, social interaction, negative reinforcer) choice procedure and reported the effects of these manipulations on cocaine choice.

Cocaine-vs-money choice Cocaine-vs-food choice Cocaine-vs-social
interaction choice
Cocaine-vs-negative
reinforcer choice
Humans Rats Monkeys Humans Rats Monkeys Humans Rats Monkeys Humans
Increase cocaine reinforcer magnitude ↑ Hart et al., 2000;Lile et al., 2016,2020;Martinez et al., 2009;Donny et al., 2003;Stoops et al., 2012 ↑ Beckmann et al., 2019*;Chow et al., 2021*;Kerstetter et al., 2012;Thomsen et al. 2008*,2013,2017*;Townsend et al. 2021 ↑ Allen et al., 2023*,2024;Banks et al., 2011*,2013a*,b*,c*;Banks & Negus 2010*;Brutcher & Nader, 2015*;Carroll et al., 2016;Czoty et al., 2005*;Czoty & Nader, 2012*,2013*,2020,2021*;Doyle et al., 2023;Foltin et al., 2015#;Hutsell et al., 2016a*, b*;John et al., 2015*;Johnson et al, 2016*;Lile et al. 2020;Moerk e et al., 2017*;Nader & Woolverton 1991,1992;Negus 2003*,2004*;Zamarippa et al., 2022 ? ↑3 Marcus et al., 2022 ? ? – Marcus & Banks, 2023 ? ?
– Lenoir et al., (2007)*
Increase alternative reinforcer magnitude ↓ Hart et al., 2000;Higgins et al., 1994;Lile et al., 2016-Donny et al., 2003;Foltin et al., 2015 ↓ Cantin 2010*;Thomsen et al. 2013 ↓ Johnson et al., 2016*;Nader & Woolverton 1991;Negus 2003* – Stoops et al., 2010 – Marcus et al., 2022 ? ? ↓4 Marcus & Banks, 2023 ? ?
Increase cocaine response requirement ↓1 Hart et al., 2000;Higgins et al., 1994;Lile et al., 2016-Foltin et al., 2015 ↓ Beasley et al., 2023*Thomsen et al. 2013; ↓ Banks et al., 2013c*;Czoty et al., 2005*;Nader & Woolverton 1992;Negus 2003* ? ↓ Bird et al., 2024, Marcus et al., 2022; Smith et al., 2023b* ? ? – Beasley et al., 2023;Marcus & Banks, 2023 ? ?
Increase alternative reinforcer response requirement ↑ Stoops et al., 2012 ↑ Beasley et al., 2023*;Cantin 2010*;Thomsen et al. 2013; ↑ Banks et al., 2013c*;Nader and Woolverton 1992; Negus 2003* ? ↑ Bird et al., 2024;Venniro et al., 2021-Smith et al., 2023b* ? ? ↑5 Beasley et al., 2023*

-Marcus & Banks, 2023
? ?
Extended access cocaine n/a ↑2 Sedighim et al., 2021 – Banks & Negus, 2010*↓Banks et al., 2013a* n/a ? ? n/a – Marcus & Banks, 2023 ? n/a

↑ increase in cocaine choice

↓ decrease in cocaine choice

– no change in choice behavior

? no published data

n/a not applicable

1

when combined with increasing money reinforcer magnitude

2

only in subjects with high addiction score

3

when combined with increasing cocaine response requirement

4

only in rats who fail to acquire avoidance-maintained responding

5

when combined with decreasing cocaine response requirement

*

only tested in males

#

only tested in females

Figure 3.

Figure 3.

Prototypical preclinical cocaine-vs-food choice dose-response curve under different environmental conditions. Based on rat and monkey literature cited in Table 1. (A) Increasing the available dose of cocaine leads to a dose-dependent increase in cocaine-vs-food choice (black line). Increasing the magnitude of the food reinforcer (blue line) shifts the dose-response curve to the right. Increasing the response requirement for cocaine (green line) or food (red line) shifts the curve down or up, respectively. (B) Increasing cocaine dose leads to decreases in the total number of reinforcers earned (black line). Increasing the magnitude of the food reinforcer has been reported to result in a slight upward shift (blue line). Increasing the food response requirement (red line) decreases the total number of reinforcers earned at low to moderate cocaine doses.

Numerous studies in rats, monkeys, and humans have altered the reinforcing magnitude of food within the choice procedure (Table 1). In preclinical drug-vs-food choice studies, subjects may or may not be food-restricted and have unlimited access to standard food in their home cage outside of the operant session. During the operant session, subjects typically have access to a non-standard food “treat” that is highly palatable and may or may not have nutritional value. In rats, the food reinforcer available during the choice session could be either a liquid such as a saccharin solution or Ensure™, or a solid such as a flavored pellet. In monkeys, the food reinforcer is conventionally a fruit-flavored pellet or liquid milk. In the studies cited in Table 1, the magnitude of the food reinforcer was altered by changing the concentration (in rats) or amount (in monkeys) of food concurrently available to cocaine. In both rats and monkeys, increasing the magnitude of the food reinforcer decreased cocaine choice. This effect can be shown graphically as a rightward shift of the cocaine choice dose-effect function (Figure 3, blue line). These reinforcer magnitude studies suggest large alternative food reinforcers will shift behavioral allocation away from cocaine, consistent with food and cocaine functioning as economic substitutes.

In cocaine-vs-food choice studies in both rats and monkeys, increasing the FR response requirement for cocaine decreases cocaine choice and shifts behavioral allocation towards food (Table 1). This effect is represented as a rightward and downward shift in the cocaine choice dose-effect function (Figure 3, green line). Inversely, increasing the FR response requirement for the food reinforcer increases cocaine choice and this effect is depicted as an upward and leftward shift of the cocaine dose-effect function (Figure 3, red line). These response requirement manipulation studies provide further empirical evidence for a high degree of economic substitutability between cocaine and food reinforcers.

Extended access conditions (i.e., 6-12h cocaine self-administration sessions) are another environmental manipulation hypothesized to impact cocaine reinforcement and underlying neurobiological mechanisms (Ahmed, 2011; Ahmed et al., 2003). For example, single-operant cocaine self-administration studies show that extended access cocaine self-administration sessions in rats results in higher progressive-ratio (PR) breakpoints suggesting that extended cocaine access increases cocaine’s reinforcing strength (Paterson and Markou, 2003). Based on these results, extended cocaine access should shift the cocaine-vs-food choice dose-effect function leftward. One monkey study tested this hypothesis and found that extended cocaine access resulted in a 10-fold increase in single operant cocaine intake but did not significantly alter cocaine-vs-food choice (Banks and Negus, 2010). Another monkey study found extended cocaine access resulted in a rightward shift in the cocaine-vs-food choice dose-effect function (Banks et al., 2013a). Consistent with these nonhuman primate data, a history of extended cocaine access failed to enhance cocaine-vs-saccharin choice in rats (Lenoir et al., 2007). Furthermore, Sedighim and colleagues (2021) showed that extended cocaine access increased PR cocaine breakpoints and decreased sensitivity to electric foot shock punishment of cocaine self-administration in a subset of rats. In addition, these subset of rats with a high “addiction score” (defined by Sedighim and colleagues as rats exhibiting escalated cocaine intake, high progressive ratio breakpoints, and responding despite adverse consequences) showed a greater preference for cocaine over food following extended cocaine access compared to rats with a low “addiction score.” One interpretative complication of this rat study is that only a single cocaine dose was tested in the choice procedure, so the full cocaine choice dose-effect function remains unknown. Overall, there is inconsistent evidence that extended cocaine access robustly alters cocaine-vs-food choice and the relative economic substitutability of cocaine and food in nonhumans.

a. Temporal dynamics of DA signaling for food reinforcement

There is ample evidence to suggest the involvement of the mesolimbic DA pathway in food reinforcement. Briefly, early microdialysis studies demonstrated nucleus accumbens (NAc) DA increased following food consumption (Doyon et al., 2004; Hajnal et al., 2004; Hernandez and Hoebel, 1988; Rada et al., 2005), and that DA antagonists impair feeding behavior (Rolls et al., 1974; Wise and Raptis, 1986; Wise and Schwartz, 1981). For full review, see (Baik, 2021; Wise, 2006). However, the literature investigating the precise temporal dynamics of mesolimbic DA signaling in food reinforcement is less robust.

There is evidence that the timing of mesolimbic DA signaling might subtly differ between cocaine and food reinforcement. In fact, some researchers theorize that DA kinetics is one of the main factors driving choice between cocaine and food such that cocaine increases DA to a larger magnitude than food, but also is more delayed temporally than food (Canchy et al., 2021). For instance, the peak NAc DA concentration was observed slightly prior to food reinforcer presentation using fast scan cyclic voltammetry (FSCV) (Cameron et al., 2014). The timing of this peak DA response differed from cocaine reinforcer presentation, in which the peak NAc DA concentration was after the drug infusion (Cameron et al., 2014). Similarly, another FSCV study found that DA release was increased in the NAc core during an audiovisual food SD (Brown et al., 2011). However, DA response during food consumption was not recorded in this study so the timing of peak DA response was not determined. In opposition of these studies which reported a DA response to the SD, an early in vivo microdialysis study found no change in NAc DA response to a food SD (Hernandez and Hoebel, 1988); however, this might be due to the poor temporal resolution of the microdialysis technique. A more temporally precise study by Kutlu and colleagues (2021) using DA fiber photometry in mice demonstrated that following operant training, NAc DA peaked in response to the SD instead of a sucrose reinforcer. Currently, there is no study that elucidates the precise timing of DA signaling in response to the three terms of the food reinforcement contingency (SD, R, and SC). Improved understanding of temporal DA neurotransmission to food reinforcement may reveal neurobiological insights into how food functions as an economic substitute for cocaine despite resulting in dramatically smaller DA increases.

b. Pharmacological treatment implications

Recently, pharmacological agents initially developed for weight loss/diabetes, such as GLP-1 agonists (e.g., semaglutide) and 5-HT2C agonists (e.g., lorcaserin), have been evaluated as candidate SUD treatments. In preclinical studies, GLP-1 and 5-HT2C agonists have been shown to decrease rates of food-maintained responding (Bernosky-Smith et al., 2016; Collins et al., 2016), likely via suppression of the mesolimbic DA system (Alhadeff et al., 2012; Matteo et al., 2002; Merkel et al., 2025). The rationale for studies investigating application of appetite-suppressant drugs as SUD treatment is founded on the hypothesis that these medications are clinically effective in part by dampening the mesolimbic DA response to food reinforcers and this effect would extend to drug reinforcers, similar to amphetamine maintenance effects on cocaine self-administration (Johnson et al., 2018). Thus, treatment with GLP-1 agonists or 5-HT2C agonists may also reduce drug self-administration towards an effective CUD treatment (for review see Jerlhag, 2023).

In line with this hypothesis, both peripheral (Sørensen et al., 2015) and central (Schmidt et al., 2016) GLP-1 agonist administration attenuated cocaine self-administration in mice and cocaine-induced reinstatement (Merkel et al., 2025). Similarly, the 5-HT2C agonist lorcaserin decreased cocaine self-administration in rats (Harvey-Lewis et al., 2016) and monkeys (Collins et al., 2016). However, in a cocaine-vs-food choice context, GLP-1 agonists and lorcaserin would fail to produce the therapeutic profile of behavioral reallocation away from cocaine and towards food within a cocaine-vs-food choice context. Treatment with either GLP-1 or 5-HT2C agonists should attenuate the reinforcing magnitude of both reinforcers through the shared reduction in mesolimbic DA signaling. The net result of GLP-1 or 5-HT2C agonist treatments on cocaine-vs-food choice would depend upon the relative sensitivity of food and cocaine to the GLP-1 or 5HT2C agonist treatment. The most likely treatment effect would be a generalized depression of operant behavior. This lack of therapeutic effect in a cocaine-vs-food choice procedure would suggest that GLP-1 or 5-HT2C agonists would be ineffective clinically.

In line with this hypothesis, repeated lorcaserin treatment failed to attenuate cocaine-vs-food choice, but decreased operant responding in monkeys (Banks and Negus, 2017b). This preclinical cocaine-vs-food choice result predicted lorcaserin’s ineffectiveness to attenuate cocaine self-administration in humans in both a human laboratory study and clinical trial (Johns et al., 2021; McCann et al., 2024). In fact, lorcaserin increased cocaine-vs-money choice (Johns et al., 2021). There are currently no preclinical or human laboratory cocaine self-administration studies determining GLP-1 agonist effects under a cocaine-choice context. Thus, even if cocaine and food function as economic substitutes in nonhumans, consideration of how pharmacological manipulations might alter behavioral allocation within an economy of multiple reinforcers will be essential to ensuring translational predictive validity of preclinical results towards the evaluation of candidate pharmacotherapies.

c. Behavioral treatment implications

Cocaine-vs-food choice procedures have not been as widely utilized in human laboratory studies as they have in preclinical studies. One study that did examine cocaine-vs-food choice in a population of non-treatment seeking individuals with CUD (Stoops et al., 2010) had participants identify food items worth various dollar amounts ($0.01 - $1.00) that they found palatable. Stoops and colleagues (2010) found that despite increasing food reinforcer magnitude (operationalized as a palatable food of a higher dollar value), participants self-administered cocaine in nearly 100% of the choice trials. This finding suggests that in humans, food may not function as an economic substitute for cocaine. These discordant results in clinical vs. preclinical food choice procedures may be due to the maximum magnitude of food reinforcers offered. Perhaps higher value foods would be chosen over cocaine. Overall, the small human cocaine-vs-food choice literature suggests that food may not be an effective means of decreasing cocaine-taking behavior in humans in a simplified choice context because cocaine and food may not function as economic substitutes.

However, preclinical cocaine-vs-food choice studies are congruent with cocaine-vs-money choice studies in humans with CUD (Table 1). For example, cocaine-vs-money choice increases with cocaine dose (Hart et al., 2000; Lile et al., 2020) where money is chosen over small cocaine doses, but not over large cocaine doses. Similarly, increasing the amount of money available as an alternative to cocaine decreased cocaine choice (Hart et al., 2000; Higgins et al., 1994; Lile et al., 2016). Additionally, cocaine choice decreased when both the cocaine response requirement and the magnitude of the alternative monetary reinforcer were high (Foltin et al., 2016, 2015). Finally, increasing the response requirement for the alternative, monetary reinforcer resulted in increased cocaine choice (Stoops et al., 2012). These results suggest that money functions as an economic substitute for cocaine in humans, and the presence of an alternative monetary reinforcer can reduce cocaine-taking behavior. These results further support the success of money-based contingency management programs in treating individuals with CUD. As previously discussed, money is a token that functions as a universal economic substitute for multiple reinforcers.

The alignment of preclinical cocaine-vs-food choice studies with human cocaine-vs-money choice studies, along with the success of contingency management programs highlights how information gleaned from preclinical studies can be used to inform clinical studies and ultimately have therapeutic applications. However, due to criticisms of monetary-based contingency management, preclinical researchers have begun to identify additional nondrug stimuli that may function as reinforcers in both preclinical and clinical procedures and act as an economic substitute for cocaine. Identifying these nondrug reinforcers can have translational implications as well as elucidate the similarities and differences in biological processes underlying reinforcement.

4. Cocaine-vs-social interaction choice

Social interaction has been established as a reinforcer in a rat preclinical drug-vs-social choice procedures (Venniro et al., 2018). In these procedures, rats lever-press for either an intravenous drug infusion or social interaction with a same-sex peer through a perforated metal barrier. The results of cocaine-vs-social interaction choice studies have shown a similar pattern of results to cocaine-vs-food choice studies (Table 1). Notably, studies report a dose-dependent increase in cocaine-vs-social interaction choice such that a same-sex peer was chosen over small cocaine doses (0.1mg/kg/inf), but as the cocaine dose increased to larger doses (1.0 mg/kg/inf) subjects allocated most of their behavior towards cocaine (Marcus et al., 2022). Additionally, increasing the cocaine response requirement promoted a behavioral reallocation to social interaction-maintained responding in both a mutually exclusive (Bird et al., 2024; Marcus et al., 2022) and non-mutually exclusive (Smith et al., 2023b) cocaine-vs-social interaction choice procedure. Inversely, increasing the response requirement (FR 8-16) for social interaction prompted rats to reallocate their behavior to cocaine (Bird et al., 2024; Venniro et al., 2021). However, increasing the response requirement for social interaction in a rat non-discrete-trial cocaine-vs-social choice procedure did not increase cocaine self-administration (Smith et al., 2023b). This is likely due to the consistently high rates of cocaine self-administration maintained by rats in this procedure. Overall, behavioral allocation between cocaine and social interaction is sensitive to both reinforcer magnitude and response requirement manipulations, indicating that cocaine and social interaction function as economic substitutes.

Given this observed economic substitutability, one would hypothesize that within a choice context, increasing the reinforcing magnitude of social interaction would promote a behavioral reallocation away from cocaine and towards the social reinforcer. One study attempted to increase the reinforcing magnitude of social interaction in a cocaine-vs-social interaction choice procedure by increasing the duration of the social interaction period (Marcus et al., 2022). However, cocaine-vs-social interaction choice behavior was unchanged. This result indicates that duration of the social interaction period is not an effective means of increasing the reinforcing magnitude of social interaction. This conclusion is further supported by evidence that increasing the duration of the social interaction period from 30 to 60 s does not affect social interaction-maintained operant responding (Baldwin et al., 2022; Chow et al., 2022).

One means of increasing social interaction reinforcer magnitude in rats may be by increasing the level of physical contact between the social pair. An early study found that the success rate of learning to emit a lever-press response for social interaction was higher when there was full physical contact between the two rat subjects (Angermeier, 1960). Additional conditioned place preference (CPP) studies have indicated that beyond just physical contact, specifically the ability to engage in play behavior with the partner rat is critical to the rewarding aspect of social interaction (Calcagnetti and Schechter 1992; Trezza et al. 2009). Thus, the removal of the metal barrier in the operant cocaine-vs-social interaction choice procedure may prompt a more robust behavioral reallocation towards social interaction. However, as rough and tumble play is more apparent during adolescence (Pellis and Pellis, 1997; Thor et al., 1985) and males initiate more play fights than females (Pellis and Pellis, 1990) increasing the level of physical contact between adult and/or female rats may have a minimal effect. Additionally, social interaction may overall have stronger rewarding properties during adolescence, as suggested by the higher social CPP scores in adolescent vs adult rats (Douglas et al., 2004). Future studies could compare cocaine-vs-social interaction choice in adolescent vs adult rats.

Other independent variables have also been manipulated to alter social interaction reinforcer magnitude in rodents. For example, one study manipulated both housing condition and familiarity with the social partner and found that rats who are single-housed and responding for a familiar partner displayed the highest rates of operant responding for social interaction (Chow et al., 2022). This result aligns with previous studies indicating that social isolation promotes social interaction (Latane and Steele, 1975). Other potential manipulations of reinforcer magnitude include attempts to alter the internal state of the animal. For instance, studies have found that rats exhibit decreased levels of social interaction in putatively anxiogenic novel testing environments (File and Seth, 2003; Varlinskaya and Spear, 2008) or while in an acute pain state (Baldwin et al., 2022). The sex of the test subject and/or the sex of the social partner may also change the magnitude of social interaction as a reinforcer. A recent study found that male rats show higher rates of social interaction-maintained responding for a female, compared to a male social partner (Chow et al., 2024). In contrast, female rats showed consistent rates of social interaction-maintained responding regardless of the sex of the social partner (Chow et al., 2024). Other studies have not reported robust sex differences with regards to operant responding for social interaction in rats (Chow et al., 2022; Sharp and Smith, 2022). Nevertheless, recent studies have suggested potential sex differences in the neural processing of social interaction (Borland et al., 2019; Li et al., 2020; Poceviciute et al., 2023).

The studies described above report independent variable manipulations that may alter reinforcing magnitude of social interaction in rodents. The extent to which the preclinical manipulations described (duration, physical closeness, age, level of familiarity, time since last social interaction, stress, pain state, or sex as a biological variable) also alter the reinforcing magnitude of social interaction in monkeys and/or humans remain outstanding research questions. This complexity of social interaction as a reinforcer highlights both future research opportunities and the difficultly in isolating what component(s) of social interaction are key to its reinforcing effects. In addition, future studies of cocaine-vs-social interaction choice in monkeys and humans could have profound translational implications for the development of effective behavioral interventions for individuals with CUD.

Drug history has been hypothesized as an independent variable that may alter cocaine-vs-social choice. In one study, rats with a limited cocaine history were evaluated in a cocaine-vs-social choice procedure. Then, rats self-administered cocaine under extended access conditions and were tested again in the choice procedure (Venniro et al., 2021). Although the study did not directly compare the effects of different access conditions on cocaine-vs-social choice, behavioral allocation appeared unchanged following extended access, suggesting that different cocaine access conditions may have a minimal effect on cocaine-vs-social choice. However, one limitation was only a single dose of cocaine (0.75 mg/kg/inf) was examined and the degree to which drug self-administration history might alter choice behavior across a range of self-administered drug doses would be a future direction towards enhancing the rigor of the literature. These future experiments could have important translational implications, as individuals with CUD have an extensive drug history. Perhaps individuals with CUD engage with social reinforcers differently or have a different neurobiological response to social reinforcement than individuals without an extensive cocaine history. This hypothesis is supported by a study in which recent cocaine exposure enhanced social interaction-maintained responding (Sharp and Smith, 2022).

a. Temporal dynamics of DA signaling in social reinforcement

Previous studies have shown that positively-valanced social interactions involve activation of the mesolimbic DA reward pathway (Chow et al., 2024; Gunaydin et al., 2014; Hu et al., 2021; Hung et al., 2017; Solié et al., 2022), suggesting a common mechanism of reinforcement between both cocaine and social interaction. In particular, a mouse study by Gunaydin and colleagues (2014) used fiber photometry to study the precise temporal dynamics of VTA-NAc signaling during interaction with a same-sex partner. Interestingly, peak VTA activity occurred during approach to a same-sex social peer. The timing of this peak activity differed from when mice were exploring a novel object, in which peak VTA activity occurred during novel object withdrawal. Similarly, Dai and colleagues (2022) found that extracellular NAc DA increased in both male and female mice during approach to an opposite sex social partner, and that this approach-induced DA increase was greater than the DA response to approaching a novel object. Furthermore, an in vivo electrophysiology study found that the majority of VTA DA neurons were active when the subject mouse was nose-to-nose with the partner (“reciprocal interaction”) or nose-to-tail with the partner (“unilateral interaction”), and very few neurons were active when the subject rat was tail-to-tail with the partner (“passive interaction”; Solié et al., 2022) during non-operant social interaction. These results provide biological evidence that social interaction might be most rewarding or reinforcing when both subjects are actively engaged.

Other studies have measured mesolimbic DA activity during operant social interaction tasks like the ones used in cocaine-vs-social interaction choice procedures. Using fluorescent biosensors, Hu and colleagues (2021) found that extracellular NAc DA increased following the performance of the operant response (nose poke), and then reached peak levels when the dividing gate started to open, signaling the onset of social interaction. During early training, DA levels remained elevated throughout the social interaction period and then decreased as the gate started to close (offset of social interaction). However, after several training days, DA levels began to decline to baseline levels during the social interaction period and decreased below baseline as the gate closed (Hu et al., 2021). Similarly, another study also found a decline in the NAc DA signal throughout the social interaction operant session (Chow et al., 2024). This is an interesting result which suggests there may be some satiety to operant responding for social interaction that may not be observed with cocaine self-administration. Further, the greater magnitude of NAc DA response to an unfamiliar vs a familiar social partner (Dai et al., 2022) combined with the lack of a correlation between NAc DA and operant demand for a social partner (Chow et al., 2024) suggests that mesolimbic DA response may be driven primarily by the novelty of the social partner rather than the magnitude of the social interaction. A future cocaine-vs-social interaction choice study using a fluorescent biosensor to monitor DA levels in the NAc could determine whether an attenuated DA signal to social interaction corresponds to a behavioral reallocation to cocaine choice.

Additionally, Solié and colleagues (2022) found that over the course of social operant training, mouse VTA DA activity measured using in vivo electrophysiology transitioned from peaking during the social interaction period to peaking during the operant lever-press response. This result is in alignment with reward prediction error theory and suggests that the timing of DA signaling may be similar across different positive reinforcement contingencies, underlying the substitutability of positive reinforcers in a concurrent choice context.

b. Pharmacological treatment implications

Social interaction may have unique reinforcing effects due to the involvement of social-specific biological mechanisms. For instance, there may be critical involvement of the “pro-social” peptide hormone oxytocin within the mesolimbic DA system during social reinforcement (Rappeneau and Castillo Díaz, 2024; Rigney et al., 2022).

Virus-based tracing studies have shown that oxytocin neurons in the paraventricular nucleus (PVN) of the hypothalamus project to VTA dopaminergic neurons (Beier et al., 2015; Hung et al., 2017). In addition, oxytocin release enhances VTA DA neuron activity (Xiao et al., 2017). One pharmacological study used a selective oxytocin receptor antagonist in adult male hamsters to demonstrate that activation of oxytocin receptors in the VTA was necessary for establishing social interaction CPP (Song et al., 2016). Similarly, Hung and colleagues (2017) showed that knocking out the oxytocin receptor selectively in the VTA prevented the development of social CPP whereas cocaine CPP remained intact, suggesting that VTA oxytocin activity was both necessary and specific to social vs drug reward. Additionally, microdialysis studies show that oxytocin administration in the VTA enhances NAc shell DA release (Melis et al., 2007; Sanna et al., 2012) and intracerebroventricular oxytocin increases medial NAc shell neuron firing rate (Moaddab et al., 2015). Interestingly, optogenetic stimulation of PVN oxytocin neurons was insufficient to produce CPP but did facilitate social CPP (Hung et al., 2017), suggesting that activation of PVN oxytocin signaling does not produce a rewarding effect alone, but may enhance social reward learning.

These CPP results suggest that determining the role of oxytocin in future cocaine-vs-social choice studies could be an interesting research direction. Studying oxytocin involvement in an operant social interaction paradigm may facilitate our understanding of the neurobiological mechanism of social interaction as a reinforcer alone or in the context of cocaine-social choice studies. For example, oxytocin administration may produce behavioral reallocation towards social interaction, while an oxytocin receptor antagonist may decrease social interaction-maintained responding and produce behavioral reallocation towards cocaine. Given the growing interest in the oxytocin system as a potential therapeutic target for substance use disorders (Bowen and Neumann, 2017; Edinoff et al., 2023; King et al., 2020; Proskynitopoulos et al., 2024; Rastogi et al., 2024; Souza et al., 2023), preclinical investigation of the influence of oxytocin receptor agonists on drug-vs-social choice may reveal a therapeutic effect, indicating the potential success of oxytocin agonists in CUD clinical trials.

c. Behavioral treatment implications

Preclinical cocaine-vs-social interaction choice studies indicate that social interaction is an economic substitute for cocaine self-administration in rats. Although there are no human laboratory studies of cocaine-vs-social interaction choice, the economic substitutability of drug and social reinforcement does appear to be maintained in a human population, as evidenced by the effectiveness of the community reinforcement approach for treating individuals with SUD. In the community reinforcement approach, individuals with SUD are encouraged to build and strengthen social relationships with nondrug-associated family members and friends (Meyers et al., 2011; Miller et al., 1999). The scientific premise is that through increasing the reinforcing magnitude of social interaction, individuals would reduce drug use and potentially achieve abstinence. Results of cocaine-vs-social interaction choice studies in rats offer preclinical evidence in support of the further development and implementation of community reinforcement programs.

Using social interaction as an alternative nondrug reinforcer in a behavioral treatment program rather than a monetary reinforcer could have several advantages. For instance, after completion of a money-based contingency management program, reductions in drug-taking behavior may not be maintained upon removal of the nondrug reinforcement contingency. In contrast, by encouraging patients to make meaningful connections with drug-abstinent or nondrug-associated family and friends, a community reinforcement-based contingency management program would facilitate sustained reductions in drug-taking behavior. This may help prevent a return to drug use after leaving the treatment program. In fact, a study in individuals receiving opioid use disorder medications found that higher loneliness scores predicted positive urine screenings at a six month-follow-up (McDonagh et al., 2020), suggesting that ameliorating feelings of social isolation may reduce drug-taking and could be used in combination with pharmacological treatment for SUD to improve treatment outcomes.

Additionally, programs that encourage social interaction as an alternative reinforcer might mitigate the current financial and practical burden of money-based contingency management programs. Recently, a randomized clinical trial of telehealth-delivered cognitive-behavioral therapy for perceived social isolation among individuals with opioid use disorder found that participants described the program as both helpful and useful (Ashrafioun et al., 2024). Further, participants who received this cognitive-behavioral therapy showed greater reductions in opioid and overall substance use compared to controls (Ashrafioun et al., 2024). These programs may represent a cost-effective and practical means of increasing engagement with social reinforcers among individuals with SUD as a means of treatment.

Additionally, cocaine is often used in social settings such that the individual is choosing to engage with cocaine and social interaction simultaneously. In this type of non-exclusive choice situation, the reinforcing properties of cocaine and social interaction may interact such that presentation of one reinforcer enhances the magnitude of the other reinforcer in an additive or synergistic fashion. In support of this hypothesis, Thiel and colleagues (2008) showed that neither peer social interaction nor a small dose of cocaine produced CPP in rats, but a combination of social interaction and the small cocaine dose did produce CPP (Thiel et al., 2008). Furthermore, studies have shown that acute cocaine pre-treatment increased operant responding for social interaction (Sharp and Smith, 2022) and that prior training on operant responding for cocaine + social interaction maintained higher PR breakpoints for social interaction than a history of responding for social interaction alone (Smith et al., 2023a). These studies would suggest that behavioral treatments attempting to implement social interaction as a mutually exclusive alternative reinforcer to cocaine may find patients reporting that social interaction has a weak reinforcing magnitude when they are not under the influence of cocaine. Thus, behavioral treatment programs would need to find ways to enhance the reinforcing magnitude of these social interactions while also decreasing drug-taking behavior. This could be achieved through engagement of fun and novel experiences with a drug-abstinent or nondrug-associated social partner. For instance, instead of having a friend over to your home to talk (familiar environment, minimally engaging activity), you and the friend could explore a museum, take a cooking class, or paint pottery (new environments with nondrug-reinforced activities).

Similarly, studies by Smith and colleagues have demonstrated that although cocaine self-administration was inhibited by concurrent access to a non-drug-taking peer, cocaine self-administration was facilitated by the presence of a co-self-administering peer. In these studies, male and female rats who were housed with a cocaine self-administering same-sex peer showed greater cocaine-maintained responding across a range of doses (0.1 – 1.0 mg/kg/inf, FR1) compared to their counterparts who were housed with a drug-abstinent same-sex peer (Robinson et al., 2017; Smith, 2012). Also, in a free-operant choice procedure, male rats exhibited higher demand for cocaine (0.5 mg/kg/inf) when social interaction with a cocaine-treated same-sex peer was available on an alternative lever, compared to when social interaction with a non-intoxicated same-sex peer was concurrently available (Smith et al., 2023b). Several additional studies from this group support the conclusion that there is a bidirectional impact of social contact on drug self-administration according to intoxication state of the peer (Peitz et al., 2013; Robinson et al., 2017; Strickland and Smith, 2014). As is true in epidemiological studies, social relationships with non-drug-using individuals exert a protective effect against the development of drug use, while relationships with drug-using individuals is a risk factor for drug use (Bahr et al., 2005; Nawi et al., 2021; Simons-Morton, 2007). Thus, behavioral treatment programs for CUD should encourage individuals in early recovery to establish social relationships with drug-abstinent peers and discourage social relationships with drug-using peers.

Group therapy and social living houses are excellent examples of effective behavioral interventions that encourage social relationships with drug-abstinent peers. A systematic review and meta-analysis found that group therapy is more effective at promoting drug abstinence, relative to individual therapy (Lo Coco et al., 2019). Additionally, sober living houses promote a host of positive recovery outcomes including sustained improvements in abstinence, frequency of substance use, legal system involvement, mental health, and employment (Polcin et al., 2010a, 2010b).Overall, this literature demonstrates how mutually exclusive vs. non-mutually exclusive choice contexts of cocaine and social interaction influence behavioral allocation. In addition, whether a social partner is drug intoxicated or not, may be important independent variables in developing behavioral or pharmacological treatment programs for people with CUD and the preclinical evaluation of candidate CUD medications.

5. Cocaine-vs-negative reinforcer choice

In addition to positive reinforcers, negative reinforcers are also available in our natural environment and may also compete with behavior maintained by commonly misused drugs. A negative reinforcer is a consequent stimulus whose removal increases the likelihood of responding (see Box 1). For example, brushing your teeth is a negatively reinforced behavior because the absence of a cavity (the negative reinforcer) increases the likelihood that you will continue to brush your teeth. In preclinical studies, foot shock is often used as a negative reinforcer, where subjects are trained to emit a response to avoid or escape the electric foot shock (Babbini et al., 1979; Berger and Brush, 1975; Sidman, 1953). In contrast to the extensive literature on cocaine-vs-positive reinforcer choice procedures described above, behavioral allocation between cocaine and a negative reinforcer has only recently been explored.

Two studies have examined behavioral allocation between cocaine and a negative reinforcer. One study utilized a discrete-trial cocaine-vs-shock avoidance/escape procedure in which rats made a mutually exclusive choice between a cocaine infusion and avoiding or escaping an electric foot shock (i.e., negative reinforcement) (Marcus and Banks, 2023). In contrast to the cocaine-vs-positive reinforcer choice procedures described above, cocaine-vs-negative reinforcer choice was insensitive to manipulations of cocaine dose such that even at large cocaine doses that were chosen over food or social interaction (1-1.8 mg/kg/inf), rats allocated the majority of their behavior to the negative reinforcement contingency. Manipulating the negative reinforcer magnitude by decreasing shock amplitude did shift behavioral allocation away from shock and towards cocaine in a sub-set of rats who failed to learn a shock avoidance response (i.e., pressing prior to the shock presentation to cancel an upcoming shock) and therefore only emitted escape responses (i.e., pressing during the shock presentation to immediately terminate the shock). This result aligns with cocaine-vs-positive reinforcer choice studies regarding cocaine choice sensitivity to nondrug reinforcer magnitude manipulations (Table 1). However, rats that learned the avoidance response were insensitive to shock amplitude manipulations because they rarely experienced the shock stimulus (Marcus and Banks, 2023).

Another study used a non-discrete trial, independent concurrent schedule of cocaine-vs-timeout from shock avoidance choice in rats to assess behavioral allocation between cocaine and a negative reinforcer and determine the effects of response requirement manipulations (Beasley et al., 2023). Similar to Marcus and Banks (2023), increasing the response requirement for the cocaine reinforcer failed to significantly attenuate cocaine choice (Beasley et al., 2023). Manipulating the response requirement for a negative reinforcer in a discrete-trial procedure is experimentally difficult because of the short, limited hold for the animal to respond before presentation of the negative reinforcer (i.e., emit an avoidance response), or emit an escape response. Due to these time constraints, the subjects failed to complete the negative reinforcer response requirement at high response requirements and did not promote a reallocation of behavior to the cocaine-associated lever (Marcus and Banks, 2023). However, Beasley and colleagues (2023) found that simultaneously increasing the response requirement for the negative reinforcer and decreasing the response requirement for the cocaine reinforcer produced an increase in cocaine choice in male rats using their independent, non-discrete trial procedure. The different results found in these two studies are likely due to the discrete-trial vs non-discrete-trial differences in the choice procedures.

Overall, there is a paucity of evidence to suggest that cocaine and electric shock as a negative reinforcer are economic substitutes. Instead, the evidence overall suggests that cocaine and negative reinforcers function as economic independents. One limitation to this conclusion is that thus far, the only negative reinforcer tested in cocaine choice procedures has been electric foot shock and the degree to which other negative reinforcers might compete with cocaine remains to be empirically determined. Additional stimuli that could be used as negative reinforcers in future choice procedures are removal of histamine infusions or removal of access to an aggressive social partner.

Cocaine self-administration under extended access conditions is hypothesized to be critical to the development of “compulsive” cocaine-taking behavior, or cocaine-taking despite adverse consequences (Ahmed, 2011; Vanderschuren and Everitt, 2004). Indeed, some rats exposed to extended access cocaine demonstrate a decreased sensitivity to shock-associated punishment of cocaine reinforcement (Belin et al., 2009; Deroche-Gamonet et al., 2004; Pelloux et al., 2007). Accordingly, one might hypothesize that extended cocaine access would lead to a reallocation of behavior away from the negative reinforcer of shock avoidance/escape and towards cocaine self-administration. However, the existing evidence demonstrates no effect of extended access cocaine on cocaine-vs-negative reinforcer choice (Marcus and Banks, 2023). These results are consistent with other studies (Ahmed et al., 2013; Pelloux et al., 2015) suggesting that persistent cocaine self-administration despite adverse consequences may be driven by a lack of alternative reinforcers available in the environment rather than reduced sensitivity to positive punishment or because of some hypothesized internal state of the subject.

a. Temporal dynamics of DA signaling in negative reinforcement

The literature regarding changes in DA signaling to aversive stimuli and the role of DA signaling in negative reinforcement learning is more nuanced. However, the extant literature does suggest a critical role for mesolimbic DA signaling in negative reinforcement (although see Fiorillo 2013) and that there may be subtle differences in mesolimbic signaling underlying positive and negative reinforcement, that may contribute to their economic non-substitutability.

Numerous studies show that aversive stimulus presentation, such as foot shocks, do elicit changes in extracellular NAc DA levels. However, there is conflicting evidence regarding the directionality of this change and thereby whether NAc DA signaling tracks the valence or the salience of the stimulus. Several studies show extracellular NAc DA decreases during foot shock using both FSCV (Oleson et al., 2012; Stelly et al., 2019) and fiber photometry (Patriarchi et al., 2018). A recent study found that aversive white noise significantly attenuated NAc DA in male and female rats (Grafelman et al., 2025). Combined with the previously discussed evidence that positive reinforcement increases mesolimbic DA signaling, these results suggest that mesolimbic DA signaling increases in response to reward (positive valence) and decreases in response to aversive stimuli (negative valence). However, other studies have shown opposite results, reporting that NAc DA increases in response to a foot shock (Kutlu et al., 2021, 2022) and tail pinch (Budygin et al., 2012), and that extracellular NAc DA increases with increasing shock intensity (Kutlu et al., 2021). These data suggest that DA signal tracks stimulus salience, regardless of valence. Often, these conflicting results are attributed to the presence of distinct cell types within various brain regions of the mesolimbic DA pathway such as the NAc (Budygin et al., 2012; de Jong et al., 2019), dorsal striatum (Hikida et al., 2010; Shin et al., 2018; Xiao et al., 2020), VTA (Brischoux et al., 2009), or amygdala (Yang et al., 2023) that respond differently to aversive stimuli. In summary, the lack of consensus in the literature regarding whether mesolimbic DA signaling (a) is associated with stimulus valence or salience, and (b) is specific to certain cell types within certain brain regions, complicates interpretation of mesolimbic DA signaling during complex behavioral contingencies such as negative reinforcement.

A study using fast-scan cyclic voltammetry (FSCV) (Stelly et al., 2019) and a study using dLight fiber photometry (Kutlu et al., 2021) trained subjects to engage in an operant response to avoid or escape a foot shock and measured extracellular NAc DA. Both studies reported an increase from baseline DA levels during the shock safety signal. This result suggests a common directionality and temporal pattern of NAc DA signaling between positive and negative reinforcement. A recent publication by Grafelman and colleagues (2025) similarly found that lever-pressing to terminate an aversive white noise resulted in increased NAc DA in male and female rats. Additionally, both Stelly (2019) and Kutlu (2021) reported that the magnitude of the NAc DA increase during the safety signal was attenuated over the course of learning the escape/avoidance response. This suggests that extracellular NAc DA response in negative reinforcement might follow the same reward prediction error theory often used to explain positive reinforcement learning in which the safety signal “reinforcer” becomes expected following extensive training of the avoidance/escape response (Schultz, 2016, 1988). However, Stelly (2019) and Kutlu (2021) reported opposite directionalities of the DA signal in response to the negative reinforcement-associated SD. To fully align with positive reinforcement DA dynamics and prediction error theory, the NAc DA signal should increase in response to the negative reinforcement-associated SD as presentation of the SD becomes associated with predicted safety signal presentation. While increases in NAc DA in response to the negative reinforcement-associated SD were found by Kutlu (2021), the studies referenced have not differentiated between avoidance and escape responses in data analysis. There are likely meaningful differences in the time course of DA response between avoidance and escape responses that could influence the economic substitutability with commonly misused drugs.

A study by Oleson and colleagues (2012) used FSCV to compare NAc DA signal between avoidance and escape responses in a discrete-trial foot shock avoidance/escape procedure. They found that the temporal pattern of DA signaling differed between the escape and avoidance responses (Oleson et al., 2012). When an escape response was emitted, rats did not show a response to the negative reinforcement-associated SD but did show a decrease in NAc DA during the shock. This was followed by an increase in DA signal upon completion of the operant response. During an avoidance response, there was an increase in DA following presentation of the negative reinforcer SD. Then, there was a further increase in DA signal after completing the operant response. These temporal dynamics (especially for escape responses) differ from the early stages of cocaine self-administration, where NAc DA remains stable until peaking seconds after the cocaine infusion (Cameron et al., 2014; Luján et al., 2023). In the Oleson (2012) study, DA response during early training was not reported, so changes over the course of training in response to the SD are unknown. Overall, the current literature suggests that negative and positive reinforcer-associated discriminative and consequent stimuli may evoke different mesolimbic DA responses. Potential differences in DA signaling could underlie the non-substitutability of positive and negative reinforcement in a concurrent choice context. Future studies of cocaine-vs-negative reinforcer choice studies combined with fiber photometry could address some outstanding questions about the similarities and differences in mesolimbic DA signaling between positive and negative reinforcement, and between avoidance and escape responses.

b. Pharmacological treatment implications

The use of cocaine-vs-negative reinforcer choice procedures to identify potential pharmacological treatments for CUD may be difficult for several reasons. First, the couple preclinical studies discussed suggest that negative reinforcement contingencies maintain high (if not near maximal) rates of responding, even when an alternative cocaine reinforcer is available. Thus, from a practical perspective, there may not be sufficient behavioral allocation towards cocaine to detect an effect of a candidate medication. Second, pharmacological manipulations that increase attentiveness to negative reinforcement contingencies may have undesirable side-effects associated with symptoms of neuropsychiatric disorders such as anxiety or obsessive-compulsive disorders, in which a harmful drive to avoid dreaded outcomes is a defining diagnostic feature.

However, drug-vs-negative reinforcer choice procedures may have utility in addressing fundamental questions about the underlying neurobiological circuitry associated with operant escape and avoidance responding. Targeting brain regions and circuits implicated in avoidance behavior, such as glutamatergic prefrontal cortex → basolateral amygdala projections (Diehl et al., 2020; Kajs et al., 2022), may selectively alter negative reinforcement-maintained responding in a cocaine-vs-negative reinforcer choice procedure. In addition, the discrete-trial negative reinforcement procedure used by Marcus and Banks (2023) produced both “Escaper” and “Avoider” rat phenotypes, resulting in the opportunity to study potential individual differences in the neural mechanisms underlying each of these negative reinforcement-maintained behaviors.

c. Behavioral treatment implications

The findings from cocaine-vs-negative reinforcer choice procedures offer an interesting perspective on methods employed in behavioral drug treatment programs. Importantly, these findings do not support the use of additional aversive stimuli to punish drug-taking behavior. Instead, these studies begin to provide some preliminary evidence in support of drug treatment programs scheduling aversive stimuli already associated with drug use (such as legal and financial repercussions) as negative reinforcers, rather than positive punishers.

Several preclinical studies have shown that punishment is not an effective means of producing drug abstinence (McNally et al., 2023; Monroe and Radke, 2021). This is in part because punishers are most effective in shaping behavior when administered immediately and consistently after every positive reinforcer. The immediacy and consistency of punishment requires constant monitoring of drug-taking behavior (Negus, 2005; Woolverton et al., 2012), which poses significant practical and financial challenge to implementation in the clinical environment by both law enforcement and healthcare providers. Instead of using punishment contingencies, negative reinforcement contingencies could be implemented to promote patient engagement in alternative behaviors that would compete with drug use. Both Beasley and colleagues (2023) and Marcus and Banks (2023) indicate that concurrently available negative reinforcement contingencies are an effective means of decreasing drug-taking behavior, and thus negative reinforcement may have clinical therapeutic potential.

A real-world example of re-scheduling punishers as negative reinforcers is the expansion of drug treatment courts (DTC). Ideally, DTCs replace drug-related incarceration (a punisher) with involvement in a local substance abuse treatment program, with legal contingencies in place. Thus, the patient can avoid incarceration by completing an operant task (e.g., community service, clinician appointments) consistent with the treatment goals and exclusive of drug use. While current DTC programs employ extensive drug-testing, these programs may not require as much costly, time-consuming, and precise monitoring of drug use because the goal is not to punish drug use, but to displace it with an alternative nondrug reinforced behavior. Additionally, once learned, avoidance contingencies are very resilient to extinction in humans (Vervliet and Indekeu, 2015), meaning that even inconsistent presentation of the aversive stimulus could maintain high rates of engagement with the negative reinforcement contingency. Negative reinforcers of lesser magnitude (i.e., monetary fines rather than incarceration) could also be used to maintain a reallocation of behavior away from drug-taking.

While scientifically sound in theory, one issue with implementing DTC is the inconsistent quality of care amongst local substance use disorder treatment clinics (Fisher, 2014). Additionally, although DTC is overall successful at reducing rates of recidivism and return to substance use (Marchand et al., 2006; Mitchell et al., 2012; Rossman et al., 2011), these outcomes are strongly influenced by social determinants of health such as race and ethnicity, education, and employment status (Wilson et al., 2018). Maintaining a consistent level of high-quality SUD care across states and counties in addition to individualizing treatment programs to account for different social determinants of health are two ways to improve the acceptability and efficacy of these behavioral treatment programs.

6. Conclusion

Studies conducted with cocaine-vs-nondrug reinforcer choice procedures have enhanced our fundamental knowledge of the behavioral and neurobiological mechanisms of CUD and have offered valuable insights on the development of behavioral and pharmacological treatments for individuals with CUD. However, there are still many opportunities to expand upon existing cocaine-vs-alternative reinforcer choice studies to have even greater neuroscience and translational implications for CUD. Three potential future directions are proposed.

One future direction for drug choice studies would be to incorporate in vivo biosensors to monitor neurotransmission simultaneously during behavioral studies to allow for a greater mechanistic understanding of neurobiological processes underlying drug and nondrug positive and negative reinforcement. Advances in this area of research may help reveal novel drug targets for CUD pharmacotherapies that may selectively block cocaine reinforcement while leaving non-dug reinforcement intact. Additionally, studies determining whether there is a reinforcer magnitude-dependent increase in NAc DA response to cocaine and nondrug reinforcers in a choice context are an important future direction to understand behavioral allocation between commonly misused drug and nondrug reinforcers. Moreover, these studies could improve our understanding of how candidate CUD medications promote behavioral reallocation away from cocaine and towards nondrug alternative reinforcers. For example, combining repeated treatment with the muscarinic agonist xanomeline with in vivo biosensors monitoring NAc DA could improve our mechanistic understanding of how xanomeline treatment attenuates cocaine-vs-food choice in rats (Thomsen et al., 2014). Completion of these studies might provide researchers with a neurobiological correlate of reinforcer magnitude which may allow for predictions of choice behavior in preclinical and ultimately clinical studies.

Second, the substitutability of cocaine and positive reinforcers in a preclinical context supports the further investigation of additional nondrug positive reinforcers that could be used to decrease drug-taking behavior. New preclinical behavioral procedures where the subject chooses between cocaine and concurrently available exercise or environmental enrichment, for example could help propel the development of additional behavioral interventions to help treat individuals with CUD. Exercise and environmental enrichment have been shown to alter cocaine conditioned place preference (Smith et al., 2008; Solinas et al., 2008; Thanos et al., 2010), and adolescent female rats with concurrent access to wheel running self-administered less cocaine than their counterparts without access to a wheel (Zlebnik et al., 2012). However, these positive reinforcers have yet to be investigated as economic commodities to cocaine in an operant choice procedure and represent a future direction for preclinical research. These proposed studies would help probe the environmental determinants of economic substitutability of different nondrug reinforcers with cocaine and develop new research areas for both mechanistic and medication development directions. Moreover, data collection in CUD clinical trials on nondrug reinforced behaviors both at baseline and following evaluation of a candidate CUD treatment would facilitate reverse translation. Currently, the primary dependent measure in clinical trials evaluating candidate pharmacotherapies is cocaine-positive urines, but an interesting and informative endpoint would be whether the candidate pharmacotherapy increased nondrug reinforced behaviors (see Acuff et al., 2024a; González-Roz et al., 2025).

Finally, sex as a biological variable has not been rigorously studied within cocaine-vs-nondrug reinforcer choice procedures (Table 1). Preclinical non-choice studies have generally found that high estradiol/low progesterone is associated with increased levels of cocaine reward and reinforcement (for reviews see Anker Justin J. and Carroll, 2011; Carroll & Anker, 2010; Moran-Santa Maria et al., 2014). Observational studies examining the subjective effects of cocaine in human participants have found similar results (Evans et al., 2002; Sofuoglu et al., 1999). However, to our knowledge very few studies have examined the effect of estrous cycle on cocaine-vs-alternative reinforcer choice. These studies report conflicting results, with one study showing that cocaine-vs-food choice does not vary across the female rat reproductive cycle (Kerstetter et al., 2012), others reporting that female rats’ food self-administration declines while cocaine self-administration remains stable (i.e., cocaine choice increases) during the proestrus/diestrus phase (Perry et al., 2015, 2013), and another reporting that the magnitude of reduction in cocaine-vs-food choice was the greatest during the monkey’s follicular phase (high estrogen) (Carroll et al., 2016). Additional studies of cocaine-vs-food choice and novel studies of cocaine-vs-social interaction or cocaine-vs-negative reinforcer choice that investigate sex as a biological variable could further our understanding of sex differences in cocaine choice behavior, how mesolimbic DA neurotransmission might be similar or different between males and females during cocaine choice behavior, and the potential influence of sex hormones. Ultimately, these studies could aid in the development of sex and gender-informed treatment methods for people with CUD.

Highlights.

  • Preclinical drug-choice studies inform pharmacological/behavioral cocaine use disorder treatments

  • Cocaine and food function as behavioral economic substitutes

  • Cocaine and social interaction also function as behavioral economic substitutes

  • Cocaine and foot shock as a negative reinforcer function as behavioral economic independents

  • Incorporating in vivo biosensors with drug-choice should improve mechanistic understanding

Funding:

Funding for this project was provided by the National Institute on Drug Abuse (F31DA059209 to MMM, R21DA053820 and R01DA055825 to MLB). Dr. Marcus also received support from T32DA007027, R34DA058494, and R01DA059483. The funding sources had no role in the interpretation, writing, or decision to submit this review for publication.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Acuff SF, Ellis JD, Rabinowitz JA, Hochheimer M, Hobelmann JG, Huhn AS, Strickland JC, 2024a. A brief measure of non-drug reinforcement: Association with treatment outcomes during initial substance use recovery. Drug Alcohol Depend 256. 10.1016/j.drugalcdep.2024.111092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Acuff SF, Strickland JC, Smith K, Field M, 2024b. Heterogeneity in choice models of addiction: the role of context. Psychopharmacology (Berl) 241, 1757–1769. 10.1007/s00213-024-06646-1 [DOI] [PubMed] [Google Scholar]
  3. Ahmed SH, 2011. Animal Models of Drug Addiction, in: Olmstead M. (Ed.), Neuromethods. Humana Press, pp. 267–292. 10.1007/978-1-60761-934-5_10 [DOI] [Google Scholar]
  4. Ahmed SH, Lenoir M, Guillem K, 2013. Neurobiology of addiction versus drug use driven by lack of choice. Curr Opin Neurobiol. 10.1016/j.conb.2013.01.028 [DOI] [PubMed] [Google Scholar]
  5. Ahmed SH, Lin D, Koob GF, Parsons LH, 2003. Escalation of cocaine self-administration does not depend on altered cocaine-induced nucleus accumbens dopamine levels. J Neurochem 86, 102–113. 10.1046/j.1471-4159.2003.01833.x [DOI] [PubMed] [Google Scholar]
  6. Alhadeff AL, Rupprecht LE, Hayes MR, 2012. GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. Endocrinology 153, 647–658. 10.1210/en.2011-1443 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Allen MI, Costa MB, Johnson BN, Gould RW, Nader MA, 2024. Cognitive performance as a behavioral phenotype associated with cocaine self-administration in female and male socially housed monkeys. Neuropsychopharmacology 49, 1729–1737. 10.1038/s41386-024-01882-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Allen MI, Johnson BN, Nader MA, 2023. A comparison of the reinforcing strength of cocaethylene and cocaine in monkeys responding under progressive-ratio and concurrent choice schedules of reinforcement. Drug Alcohol Depend 251. 10.1016/j.drugalcdep.2023.110952 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Angermeier WF, 1960. Some basic aspects of social reinforcements in albino rats. J Comp Physiol Psychol 53, 364–367. [Google Scholar]
  10. Anker JJ, Carroll ME, 2011. Females Are More Vulnerable to Drug Abuse than Males: Evidence from Preclinical Studies and the Role of Ovarian Hormones, in: Neill Jo C. and Kulkarni J. (Ed.), Biological Basis of Sex Differences in Psychopharmacology. Springer Berlin Heidelberg, Berlin, Heidelberg, pp. 73–96. 10.1007/7854_2010_93 [DOI] [PubMed] [Google Scholar]
  11. Ashrafioun L, Allan NP, Stecker TA, 2024. A randomized clinical trial to assess feasibility, acceptability and preliminary effects of telehealth-delivered cognitive-behavioral therapy for perceived social isolation among individuals with opioid use disorders. Drug Alcohol Depend 258, 111268. 10.1016/j.drugalcdep.2024.111268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Babbini M, Gaiardi M, Bartoletti M, 1979. Stimulus-response relationships in a quickly learned escape from shock: Effects of morphine. Pharmacol Biochem Behav 11, 155–158. [DOI] [PubMed] [Google Scholar]
  13. Bahr SJ, Hoffmann JP, Yang X, 2005. Parental and peer influences on the risk of adolescent drug use. Journal of Primary Prevention 26, 529–551. 10.1007/s10935-005-0014-8 [DOI] [PubMed] [Google Scholar]
  14. Baik JH, 2021. Dopaminergic control of the feeding circuit. Endocrinology and Metabolism 36, 229–239. 10.3803/ENM.2021.979 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Baldwin AN, Banks ML, Marsh SA, Townsend EA, Venniro M, Shaham Y, Negus SS, 2022. Acute pain-related depression of operant responding maintained by social interaction or food in male and female rats. Psychopharmacology (Berl) 239, 561–572. 10.1007/s00213-021-06048-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Banks ML, Blough BE, Fennell TR, Snyder RW, Negus SS, 2013a. Effects of phendimetrazine treatment on cocaine vs food choice and extended-access cocaine consumption in rhesus monkeys. Neuropsychopharmacology 38, 2698–2707. 10.1038/npp.2013.180 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Banks ML, Blough BE, Negus SS, 2013b. Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys. Drug Alcohol Depend 131, 204–213. 10.1016/j.drugalcdep.2013.05.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Banks ML, Blough BE, Negus SS, 2013c. Interaction between behavioral and pharmacological treatment strategies to decrease cocaine choice in rhesus monkeys. Neuropsychopharmacology 38, 395–404. 10.1038/npp.2012.193 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Banks ML, Blough BE, Negus SS, 2011. Effects of monoamine releasers with varying selectivity for releasing dopamine/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys. Behavioural Pharmacology 22, 824–836. 10.1097/FBP.0b013e32834d63ac [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Banks ML, Negus SS, 2017a. Insights from Preclinical Choice Models on Treating Drug Addiction. Trends Pharmacol Sci 38, 181–194. 10.1016/j.tips.2016.11.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Banks ML, Negus SS, 2017b. Repeated 7-Day Treatment with the 5-HT 2C Agonist Lorcaserin or the 5-HT 2A Antagonist Pimavanserin Alone or in Combination Fails to Reduce Cocaine vs Food Choice in Male Rhesus Monkeys. Neuropsychopharmacology 42, 1082–1092. 10.1038/npp.2016.259 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Banks ML, Negus SS, 2010. Effects of extended cocaine access and cocaine withdrawal on choice between cocaine and food in rhesus monkeys. Neuropsychopharmacology 35, 493–504. 10.1038/npp.2009.154 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Banks ML, Negus SS, 2012. Preclinical determinants of drug choice under concurrent schedules of drug self-administration. Adv Pharmacol Sci 2012. 10.1155/2012/281768 [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Banks ML, Townsend EA, Negus SS, 2019. Testing the 10 most wanted: a preclinical algorithm to screen candidate opioid use disorder medications. Neuropsychopharmacology. 10.1038/s41386-019-0336-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Beasley MM, Amantini S, Gunawan T, Silberberg A, Kearns DN, 2023. Cocaine and heroin interact differently with nondrug reinforcers in a choice situation. Exp Clin Psychopharmacol. 10.1037/pha0000674 [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Beckmann JS, Chow JJ, Hutsell BA, 2019. Cocaine-associated decision-making: Toward isolating preference. Neuropharmacology 153, 142–152. 10.1016/j.neuropharm.2019.03.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Beier KT, Steinberg EE, Deloach KE, Xie S, Miyamichi K, Schwarz L, Gao XJ, Kremer EJ, Malenka RC, Luo L, 2015. Circuit architecture of VTA dopamine neurons revealed by systematic input-output mapping. Cell 162, 622–634. 10.1016/j.cell.2015.07.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Belin D, Balado E, Piazza PV, Deroche-Gamonet V, 2009. Pattern of intake and drug craving predict the development of cocaine addiction-like behavior in rats. Biol Psychiatry 65, 863–868. 10.1016/j.biopsych.2008.05.031 [DOI] [PubMed] [Google Scholar]
  29. Bentzley BS, Han SS, Neuner S, Humphreys K, Kampman KM, Halpern CH, 2021. Comparison of treatments for cocaine use disorder among adults: A systematic review and meta-analysis. JAMA Netw Open 4. 10.1001/jamanetworkopen.2021.8049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Berger DF, Brush FR, 1975. Rapid acquisition of discrete-trial lever-press avoidance: Effects of signal-shock interval. J Exp Anal Behav 24, 227–239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Bernosky-Smith KA, Stanger DB, Trujillo AJ, Mitchell LR, España RA, Bass CE, 2016. The GLP-1 agonist exendin-4 attenuates self-administration of sweetened fat on fixed and progressive ratio schedules of reinforcement in rats. Pharmacol Biochem Behav 142, 48–55. 10.1016/j.pbb.2015.12.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Bird T, Beasley MM, Pilz EM, Amantini S, Lopez KC, Silberberg A, Kearns DN, 2024. An investigation of economic interactions between social reinforcement and heroin or cocaine in rats. Behavioural Pharmacology. 10.1097/FBP.0000000000000798 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Borland JM, Aiani LM, Norvelle A, Grantham KN, O’Laughlin K, Terranova JI, Frantz KJ, Albers HE, 2019. Sex-dependent regulation of social reward by oxytocin receptors in the ventral tegmental area. Neuropsychopharmacology 44, 785–792. 10.1038/s41386-018-0262-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Bowen MT, Neumann ID, 2017. Rebalancing the Addicted Brain: Oxytocin Interference with the Neural Substrates of Addiction. Trends Neurosci. 10.1016/j.tins.2017.10.003 [DOI] [PubMed] [Google Scholar]
  35. Brischoux F, Chakraborty S, Brierley DI, Ungless MA, 2009. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. PNAS 106, 4894–4899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Brown HD, Mccutcheon JE, Cone JJ, Ragozzino ME, Roitman MF, 2011. Primary food reward and reward-predictive stimuli evoke different patterns of phasic dopamine signaling throughout the striatum. European Journal of Neuroscience 34, 1997–2006. 10.1111/j.1460-9568.2011.07914.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Brutcher RE, Nader MA, 2015. Effects of quetiapine treatment on cocaine self-administration and behavioral indices of sleep in adult rhesus monkeys. Psychopharmacology (Berl) 232, 411–420. 10.1007/s00213-014-3672-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Budygin EA, Park J, Bass CE, Grinevich VP, Bonin KD, Wightman RM, 2012. Aversive stimulus differentially triggers subsecond dopamine release in reward regions. Neuroscience 201, 331–337. 10.1016/j.neuroscience.2011.10.056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Calcagnetti DJ, Schechter MD, 1992. Place Conditioning Reveals the Rewarding Aspect of Social Interaction in Juvenile Rats. Physiol Behav 51, 667–672. [DOI] [PubMed] [Google Scholar]
  40. Cameron CM, Wightman RM, Carelli RM, 2014. Dynamics of rapid dopamine release in the nucleus accumbens during goal-directed behaviors for cocaine versus natural rewards. Neuropharmacology 86, 319–328. 10.1016/j.neuropharm.2014.08.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Canchy L, Girardeau P, Durand A, Vouillac-Mendoza C, Ahmed SH, 2021. Pharmacokinetics trumps pharmacodynamics during cocaine choice: a reconciliation with the dopamine hypothesis of addiction. Neuropsychopharmacology 46, 288–296. 10.1038/s41386-020-0786-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Cantin L, Lenoir M, Augier E, Vanhille N, Dubreucq S, Serre F, Vouillac C, Ahmed SH, 2010. Cocaine is low on the value ladder of rats: Possible evidence for resilience to addiction. PLoS One 5, 1–14. 10.1371/journal.pone.0011592 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Carroll ME, Anker JJ, 2010. Sex differences and ovarian hormones in animal models of drug dependence. Horm Behav. 10.1016/j.yhbeh.2009.10.001 [DOI] [PubMed] [Google Scholar]
  44. Carroll ME, Collins M, Kohl EA, Johnson S, Dougen B, 2016. Sex and menstrual cycle effects on chronic oral cocaine self-administration in rhesus monkeys: Effects of a nondrug alternative reward. Psychopharmacology (Berl) 233, 2973–2984. 10.1007/s00213-016-4343-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Chow JJ, Beacher NJ, Chabot JM, Oke M, Venniro M, Lin DT, Shaham Y, 2022. Characterization of operant social interaction in rats: effects of access duration, effort, peer familiarity, housing conditions, and choice between social interaction vs. food or remifentanil. Psychopharmacology (Berl) 239, 2093–2108. 10.1007/s00213-022-06064-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Chow JJ, Hofford RS, Beckmann JS, 2021. Neuronal activity associated with cocaine preference: Effects of differential cocaine intake. Neuropharmacology 184. 10.1016/j.neuropharm.2020.108441 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Chow JJ, Pitts KM, Schoenbaum A, Costa KM, Schoenbaum G, Shaham Y, 2024. Different effects of peer-sex on operant responding for social interaction and striatal dopamine activity. The Journal of Neuroscience e1887232024. 10.1523/jneurosci.1887-23.2024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Collins GT, Gerak LR, Javors MA, France CP, 2016. Lorcaserin Reduces the Discriminative Stimulus and Reinforcing Effects of Cocaine in Rhesus Monkeys. J Pharmacol Exp Ther 356, 85–95. 10.1124/jpet.115.228833 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Czoty PW, McCabe C, Nader MA, 2005. Assessment of the relative reinforcing strength of cocaine in socially housed monkeys using a choice procedure. Journal of Pharmacology and Experimental Therapeutics 312, 96–102. 10.1124/jpet.104.073411 [DOI] [PubMed] [Google Scholar]
  50. Czoty PW, Nader MA, 2012. Individual differences in the effects of environmental stimuli on cocaine choice in socially housed male cynomolgus monkeys. Psychopharmacology (Berl) 224, 69–79. 10.1007/s00213-011-2562-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Czoty PW, Nader MA, 2013. Effects of dopamine D2/D3 receptor ligands on food-cocaine choice in socially housed male cynomolgus monkeys. Journal of Pharmacology and Experimental Therapeutics 344, 329–338. 10.1124/jpet.112.201012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Czoty PW, Nader MA, 2020. Effects of the a-2 adrenergic receptor agonists lofexidine and guanfacine on food-cocaine choice in socially housed cynomolgus monkeys. Journal of Pharmacology and Experimental Therapeutics 375, 193–201. 10.1124/JPET.120.266007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Czoty PW, Nader MA, 2021. Effects of Dopamine D1-Like Receptor Ligands on Food-Cocaine Choice in Socially Housed Male Cynomolgus Monkeys. Journal of Pharmacology and Experimental Therapeutics 379, 12–19. 10.1124/jpet.121.000701 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Dai B, Sun F, Tong X, Ding Y, Kuang A, Osakada T, Li Y, Lin D, 2022. Responses and functions of dopamine in nucleus accumbens core during social behaviors. Cell Rep 40. 10.1016/j.celrep.2022.111246 [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. de Jong JW, Afjei SA, Pollak Dorocic I, Peck JR, Liu C, Kim CK, Tian L, Deisseroth K, Lammel S, 2019. A neural circuit mechanism for encoding aversive stimuli in the mesolimbic dopamine system. Neuron 101, 133–151.e7. 10.1016/j.neuron.2018.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Deroche-Gamonet V, Belin D, Piazza PV, 2004. Evidence for addiction-like behavior in the rat. Science 305, 1014–1017. [DOI] [PubMed] [Google Scholar]
  57. Diehl MM, Iravedra-Garcia JM, Morán-Sierra J, Rojas-Bowe G, Gonzalez-Diaz FN, Valentín-Valentín VP, Quirk GJ, 2020. Divergent projections of the prelimbic cortex bidirectionally regulate active avoidance. Elife 9, 1–13. 10.7554/eLife.59281 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Donny EC, Bigelow GE, Walsh SL, 2003. Choosing to take cocaine in the human laboratory: effects of cocaine dose, inter-choice interval, and magnitude of alternative reinforcement. DrugandAlcoholDependence 289–301. [DOI] [PubMed] [Google Scholar]
  59. Douglas LA, Varlinskaya EI, Spear LP, 2004. Rewarding properties of social interactions in adolescent and adult male and female rats: Impact of social versus isolate housing of subjects and partners. Dev Psychobiol 45, 153–162. 10.1002/dev.20025 [DOI] [PubMed] [Google Scholar]
  60. Doyle WS, Freeman KB, Woods J, Huskinson SL, 2023. Choice between food and cocaine or fentanyl reinforcers under fixed and variable schedules in female and male rhesus monkeys. Psychopharmacology (Berl) 240, 1573–1585. 10.1007/s00213-023-06391-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Doyon WM, Ramachandra V, Samson HH, Czachowski CL, Gonzales RA, 2004. Accumbal dopamine concentration during operant self-administration of a sucrose or a novel sucrose with ethanol solution. Alcohol 34, 261–271. 10.1016/j.alcohol.2004.10.004 [DOI] [PubMed] [Google Scholar]
  62. Edinoff AN, Sall S, Honore LG, Dies RM, Zaheri AR, Kataria S, Jackson ED, Shekoohi S, Cornett EM, Murnane KS, Kaye AM, Kaye AD, 2023. The Use of Oxytocin for the Treatment of Opioid Use Disorder. Curr Pain Headache Rep 27, 89–97. 10.1007/s11916-023-01105-6 [DOI] [PubMed] [Google Scholar]
  63. Evans SM, Haney M, Foltin RW, 2002. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) 159, 397–406. 10.1007/s00213-001-0944-7 [DOI] [PubMed] [Google Scholar]
  64. File SE, Seth P, 2003. A review of 25 years of the social interaction test. Eur J Pharmacol. 10.1016/S0014-2999(03)01273-1 [DOI] [PubMed] [Google Scholar]
  65. Fiorillo CD, 2013. Two dimensions of value: Dopamine neurons represent reward but not aversiveness. Science 341, 546–549. 10.1126/science.1239213 [DOI] [PubMed] [Google Scholar]
  66. Fischer B, O’Keefe-Markman C, Lee A, Daldegan-Bueno D, 2021. ‘Resurgent’, ‘twin’ or ‘silent’ epidemic? A select data overview and observations on increasing psycho-stimulant use and harms in North America. Subst Abuse Treat Prev Policy 16. 10.1186/s13011-021-00350-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Fisher C, 2014. Treating the Disease or Punishing the Criminal?: Effectively Using Drug Court Sanctions to Treat Substance Use Disorder and Decrease Criminal Conduct Caitlinrose Fisher. Minn Law Rev 99, 747–781. [Google Scholar]
  68. Foltin RW, Haney M, Bedi G, Evans SM, 2016. Modafinil decreases cocaine choice in human cocaine smokers only when the response requirement and the alternative reinforcer magnitude are large. Pharmacol Biochem Behav 150–151, 8–13. 10.1016/j.pbb.2016.08.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Foltin RW, Haney M, Rubin E, Reed SC, Vadhan N, Balter R, Evans SM, 2015. Development of translational preclinical models in substance abuse: Effects of cocaine administration on cocaine choice in humans and non-human primates. Pharmacol Biochem Behav 134, 12–21. 10.1016/j.pbb.2015.03.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. González-Roz A, Secades-Villa R, Alemán-Moussa L, 2025. Validity evidence and clinical utility of the Oviedo Leisure Activities Scale (OLAS-70) for measuring substance-free and substance-related reinforcement. Exp Clin Psychopharmacol. 10.1037/pha0000771 [DOI] [PubMed] [Google Scholar]
  71. Grafelman EM, Côté BE, Vlach L, Geise E, Padula GN, Wheeler DS, Hearing MC, Mantsch JR, Wheeler RA, 2025. Aversion-induced dopamine reductions predict drug-taking and escape behaviors. Neuropsychopharmacology. 10.1038/s41386-025-02101-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Gunaydin LA, Grosenick L, Finkelstein JC, Kauvar IV, Fenno LE, Adhikari A, Lammel S, Mirzabekov JJ, Airan RD, Zalocusky KA, Tye KM, Anikeeva P, Malenka RC, Deisseroth K, 2014. Natural neural projection dynamics underlying social behavior. Cell 157, 1535–1551. 10.1016/j.cell.2014.05.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Hajnal A, Smith GP, Norgren R, 2004. Oral sucrose stimulation increases accumbens dopamine in the rat. Am J Physiol Regul Integr Comp Physiol 286, 31–37. 10.1152/ajpregu.00282.2003.-Although [DOI] [PubMed] [Google Scholar]
  74. Hart CL, Haney M, Foltin RW, Fischman MW, 2000. Alternative reinforcers differentially modify cocaine self-administration by humans. Behavioural Pharmacology 11, 87–91. 10.1097/00008877-200002000-00010 [DOI] [PubMed] [Google Scholar]
  75. Harvey-Lewis C, Li Z, Higgins GA, Fletcher PJ, 2016. The 5-HT2C receptor agonist lorcaserin reduces cocaine self-administration, reinstatement of cocaine-seeking and cocaine induced locomotor activity. Neuropharmacology 101, 237–245. 10.1016/j.neuropharm.2015.09.028 [DOI] [PubMed] [Google Scholar]
  76. Hernandez L, Hoebel BG, 1988. Food reward and cocaine increase extracellular dopamine in the nucleus accumbens as measured by microdialysis. Life Sci 42, 1705–1712. [DOI] [PubMed] [Google Scholar]
  77. Heyman GM, 2009. Addiction: A disorder of choice., Addiction: A disorder of choice. Harvard University Press, Cambridge, MA, US. [Google Scholar]
  78. Higgins ST, Bickel WK, Hughes JR, 1994. Influence of an alternative reinforcer on human cocaine self-administration. Life Sci 55, 179–187. [DOI] [PubMed] [Google Scholar]
  79. Hikida T, Kimura K, Wada N, Funabiki K, Nakanishi Shigetada S, 2010. Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 66, 896–907. 10.1016/j.neuron.2010.05.011 [DOI] [PubMed] [Google Scholar]
  80. Hu RK, Zuo Y, Ly T, Wang J, Meera P, Wu YE, Hong W, 2021. An amygdala-to-hypothalamus circuit for social reward. Nat Neurosci 24, 831–842. 10.1038/s41593-021-00828-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Hung LW, Neuner S, Polepalli JS, Beier KT, Wright M, Walsh JJ, Lewis EM, Luo L, Deisseroth K, Dölen G, Malenka RC, 2017. Gating of social reward by oxytocin in the ventral tegmental area. Science 357, 1406–1411. 10.1126/science.aan4994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Hutsell BA, Cheng K, Rice KC, Negus SS, Banks ML, 2016a. Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys. Addiction Biology 21, 360–373. 10.1111/adb.12206 [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Hutsell BA, Negus SS, Banks ML, 2016b. Effects of 21-day d-amphetamine and risperidone treatment on cocaine vs food choice and extended-access cocaine intake in male rhesus monkeys. Drug Alcohol Depend 168, 36–44. 10.1016/j.drugalcdep.2016.08.637 [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Jerlhag E, 2023. The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies. Front Pharmacol 14. 10.3389/fphar.2023.1063033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. John WS, Banala AK, Newman AH, Nader MA, 2015. Effects of buspirone and the dopamine D3 receptor compound PG619 on cocaine and methamphetamine self-administration in rhesus monkeys using a food-drug choice paradigm. Psychopharmacology (Berl) 232, 1279–1289. 10.1007/s00213-014-3760-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Johns SE, Keyser-Marcus L, Abbate A, Boone E, Van Tassell B, Cunningham KA, Anastasio NC, Poklis JL, Ramey T, Moeller FG, 2021. Safety and Preliminary Efficacy of Lorcaserin for Cocaine Use Disorder: A Phase I Randomized Clinical Trial. Front Psychiatry 12. 10.3389/fpsyt.2021.666945 [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Johnson AR, Banks ML, Blough BE, Lile JA, Nicholson KL, Negus SS, 2016. Development of a translational model to screen medications for cocaine use disorder I: Choice between cocaine and food in rhesus monkeys. Drug Alcohol Depend 165, 103–110. 10.1016/j.drugalcdep.2016.05.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Johnson AR, Banks ML, Selley DE, Negus SS, 2018. Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats. Neuropsychopharmacology 43, 1753–1762. 10.1038/s41386-018-0071-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Jones CMC, Baldwin GT, Compton WM, 2017. Recent increases in cocaine-related overdose deaths and the role of opioids. Am J Public Health. 10.2105/AJPH.2016.303627 [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Kajs BL, Loewke AC, Dorsch JM, Vinson LT, Gunaydin LA, 2022. Divergent encoding of active avoidance behavior in corticostriatal and corticolimbic projections. Sci Rep 12. 10.1038/s41598-022-14930-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Kampman KM, 2019. The treatment of cocaine use disorder. Sci. Adv 5, 1532–1548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Kerstetter KA, Ballis MA, Duffin-Lutgen S, Carr AE, Behrens AM, Kippin TE, 2012. Sex differences in selecting between food and cocaine reinforcement are mediated by estrogen. Neuropsychopharmacology 37, 2605–2614. 10.1038/npp.2012.99 [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. King CE, Gano A, Becker HC, 2020. The role of oxytocin in alcohol and drug abuse. Brain Res 1736. 10.1016/j.brainres.2020.146761 [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Koob GF, 2020. Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement. Biol Psychiatry 87, 44–53. 10.1016/j.biopsych.2019.05.023 [DOI] [PubMed] [Google Scholar]
  95. Kutlu MG, Zachry JE, Melugin PR, Cajigas SA, Chevee MF, Kelly SJ, Kutlu B, Tian L, Siciliano CA, Calipari ES, 2021. Dopamine release in the nucleus accumbens core signals perceived saliency. Current Biology 31, 4748–4761.e8. 10.1016/j.cub.2021.08.052 [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Kutlu MG, Zachry JE, Melugin PR, Tat J, Cajigas S, Isiktas AU, Patel DD, Siciliano CA, Schoenbaum G, Sharpe MJ, Calipari ES, 2022. Dopamine signaling in the nucleus accumbens core mediates latent inhibition. Nat Neurosci 25, 1071–1081. 10.1038/s41593-022-01126-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Lamb RJ, Ginsburg BC, 2018. Addiction as a BAD, a Behavioral Allocation Disorder. Pharmacol Biochem Behav 164, 62–70. 10.1016/j.pbb.2017.05.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Latane B, Steele C, 1975. The persistence of social attraction in socially deprived and satiated rats. Anim Learn Behav 3, 131–134. [Google Scholar]
  99. Lenoir M, Serre F, Cantin L, Ahmed SH, 2007. Intense sweetness surpasses cocaine reward. PLoS One 2. 10.1371/journal.pone.0000698 [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Li G, Chen Y, Wang W, Dhingra I, Zhornitsky S, Tang X, Li CSR, 2020. Sex differences in neural responses to the perception of social interactions. Front Hum Neurosci 14. 10.3389/fnhum.2020.565132 [DOI] [PMC free article] [PubMed] [Google Scholar]
  101. Lile JA, Johnson AR, Banks ML, Hatton KW, Hays LR, Nicholson KL, Poklis JL, Rayapati AO, Rush CR, Stoops WW, Negus SS, 2020. Pharmacological validation of a translational model of cocaine use disorder: Effects of d-amphetamine maintenance on choice between intravenous cocaine and a nondrug alternative in humans and rhesus monkeys. Exp Clin Psychopharmacol 28. 10.1037/pha0000302 [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Lile JA, Stoops WW, Rush CR, Negus SS, Glaser PEA, Hatton KW, Hays LR, 2016. Development of a translational model to screen medications for cocaine use disorder II: Choice between intravenous cocaine and money in humans. Drug Alcohol Depend 165, 111–119. 10.1016/j.drugalcdep.2016.05.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Lipari RN, Park-Lee E, 2020. Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health. [Google Scholar]
  104. Lo Coco G, Melchiori F, Oieni V, Infurna MR, Strauss B, Schwartze D, Rosendahl J, Gullo S, 2019. Group treatment for substance use disorder in adults: A systematic review and meta-analysis of randomized-controlled trials. J Subst Abuse Treat 99, 104–116. 10.1016/j.jsat.2019.01.016 [DOI] [PubMed] [Google Scholar]
  105. Luján MÁ, Oliver BL, Young-Morrison R, Engi SA, Zhang L-Y, Wenzel JM, Li Y, Zlebnik NE, Cheer JF, 2023. A multivariate regressor of patterned dopamine release predicts relapse to cocaine. Cell Rep 42, 112553. 10.1016/j.celrep.2023.112553 [DOI] [PubMed] [Google Scholar]
  106. Marchand G, Mark Waller M, Shannon Carey BM, 2006. Barry County Adult Drug Court Outcome and Cost Evaluation. Portland, OR: NPC Research. [Google Scholar]
  107. Marcus MM, Banks ML, 2023. Effects of environmental and pharmacological manipulations on cocaine-vs-negative reinforcer choice in male and female rats. Psychopharmacology (Berl) 240, 1677–1689. 10.1007/s00213-023-06404-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Marcus MM, Marsh SA, Arriaga M, Negus SS, Banks ML, 2024. Effects of pharmacological and environmental manipulations on choice between fentanyl and shock avoidance/escape in male and female rats under mutually exclusive and non-exclusive choice conditions. Neuropsychopharmacology 49, 2011–2021. 10.1038/s41386-024-01939-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Marcus MM, Negus SS, Banks ML, 2022. Effects of environmental manipulations on cocaine-vs-social choice in male and female rats. Pharmacol Biochem Behav 220, 1–9. 10.1016/j.pbb.2022.173462 [DOI] [PMC free article] [PubMed] [Google Scholar]
  110. Martinez D, Slifstein M, Narendran R, Foltin RW, Broft A, Hwang DR, Perez A, Abi-Dargham A, Fischman MW, Kleber HD, Laruelle M, 2009. Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine. Neuropsychopharmacology 34, 1774–1782. 10.1038/npp.2008.235 [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Di Matteo V, Cacchio M, Di Giulio C, Esposito E, 2002. Role of serotonin 2C receptors in the control of brain dopaminergic function. Pharmacol Biochem Behav 71, 727–734. [DOI] [PubMed] [Google Scholar]
  112. McCann DJ, Chen HH, Devine EG, Gyaw S, Ramey T, 2024. Results of a randomized, double-blind, placebo-controlled trial of lorcaserin in cocaine use disorder. Drug Alcohol Depend 255. 10.1016/j.drugalcdep.2023.111063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. McDonagh J, Williams CB, Oldfield BJ, Cruz-Jose D, Olson DP, 2020. The Association of Loneliness and Non-prescribed Opioid Use in Patients with Opioid Use Disorder. J Addict Med 14, 489–493. 10.1097/ADM.0000000000000629 [DOI] [PubMed] [Google Scholar]
  114. McNally GP, Jean-Richard-dit-Bressel P, Millan EZ, Lawrence AJ, 2023. Pathways to the persistence of drug use despite its adverse consequences. Mol Psychiatry 28, 2228–2237. 10.1038/s41380-023-02040-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Melis MR, Melis T, Cocco C, Succu S, Sanna F, Pillolla G, Boi A, Ferri GL, Argiolas A, 2007. Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats. European Journal of Neuroscience 26, 1026–1035. 10.1111/j.1460-9568.2007.05721.x [DOI] [PubMed] [Google Scholar]
  116. Merkel R, Hernandez NS, Weir V, Zhang Y, Caffrey A, Rich MT, Crist RC, Reiner BC, Schmidt HD, 2025. An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Meyers RJ, Roozen HG, Smith JE, 2011. The community reinforcement approach: an update on the evidence. Alcohol Research and Health 33, 380–388. [PMC free article] [PubMed] [Google Scholar]
  118. Miller WR, Meyers RJ, Hiller-Sturmhöfel S, 1999. The Community-Reinforcement Approach. Alcohol Research & Health 23, 116–121. [PMC free article] [PubMed] [Google Scholar]
  119. Mitchell O, Wilson DB, Eggers A, MacKenzie DL, 2012. Assessing the effectiveness of drug courts on recidivism: A meta-analytic review of traditional and non-traditional drug courts. J Crim Justice 40, 60–71. 10.1016/j.jcrimjus.2011.11.009 [DOI] [Google Scholar]
  120. Moaddab M, Hyland BI, Brown CH, 2015. Oxytocin excites nucleus accumbens shell neurons in vivo. Molecular and Cellular Neuroscience 68, 323–330. 10.1016/j.mcn.2015.08.013 [DOI] [PubMed] [Google Scholar]
  121. Moerke MJ, Banks ML, Cheng K, Rice KC, Negus SS, 2017. Maintenance on naltrexone + amphetamine decreases cocaine-vs.-food choice in male rhesus monkeys. Drug Alcohol Depend 181, 85–93. 10.1016/j.drugalcdep.2017.09.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Monroe SC, Radke AK, 2021. Aversion-resistant fentanyl self-administration in mice. Psychopharmacology (Berl) 238, 699–710. 10.1007/s00213-020-05722-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Moran-Santa Maria MM, Flanagan J, Brady K, 2014. Ovarian hormones and drug abuse. Curr Psychiatry Rep. 10.1007/s11920-014-0511-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Nader MA, Woolverton WL, 1991. Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure. Psychopharmacology (Berl) 105, 169–174. 10.1007/BF02244304 [DOI] [PubMed] [Google Scholar]
  125. Nader MA, Woolverton WL, 1992. Effects of increasing response requirement on choice between cocaine and food in rhesus monkeys. Psychopharmacology (Berl) 108, 295–300. 10.1007/BF02245115 [DOI] [PubMed] [Google Scholar]
  126. National Institute on Drug Abuse, 2023. Drug Overdose Death Rates. URL https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates (accessed 9.20.23).
  127. National Survey on Drug Use and Health, 2021. NSDUH 2021 Data Collection Final Report. [Google Scholar]
  128. Nawi AM, Ismail R, Ibrahim F, Hassan MR, Manaf MRA, Amit N, Ibrahim N, Shafurdin NS, 2021. Risk and protective factors of drug abuse among adolescents: a systematic review. BMC Public Health 21. 10.1186/s12889-021-11906-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Negus SS, 2004. Effects of the kappa opioid agonist U50,488 and the kappa opioid antagonist nor-binaltorphimine on choice between cocaine and food in rhesus monkeys. Psychopharmacology (Berl) 176, 204–213. 10.1007/s00213-004-1878-7 [DOI] [PubMed] [Google Scholar]
  130. Negus SS, 2005. Effects of punishment on choice between cocaine and food in rhesus monkeys. Psychopharmacology (Berl) 181, 244–252. 10.1007/s00213-005-2266-7 [DOI] [PubMed] [Google Scholar]
  131. Negus SS, Banks ML, 2018. Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development. Pharmacol Biochem Behav 164, 32–39. 10.1016/j.pbb.2017.04.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Negus SS, Banks ML, 2020. Learning from lorcaserin: Lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder. Neuropsychopharmacology 45, 1967–1973. 10.1038/s41386-020-00815-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Negus SS, Banks ML, 2021. Confronting the challenge of failed translation in medications development for substance use disorders. Pharmacol Biochem Behav 210. 10.1016/j.pbb.2021.173264 [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Oleson EB, Gentry RN, Chioma VC, Cheer JF, 2012. Subsecond dopamine release in the nucleus accumbens predicts conditioned punishment and its successful avoidance. Journal of Neuroscience 32, 14804–14808. 10.1523/JNEUROSCI.3087-12.2012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Paterson NE, Markou A, 2003. Increased motivation for self-administered cocaine after escalated cocaine intake. Neuroreport 14, 2229–2232. 10.1097/01.wnr.0000091685.94870.ba [DOI] [PubMed] [Google Scholar]
  136. Patriarchi T, Cho JR, Merten K, Howe MW, Marley A, Xiong WH, Folk RW, Broussard GJ, Liang R, Jang MJ, Zhong H, Dombeck D, von Zastrow M, Nimmerjahn A, Gradinaru V, Williams JT, Tian L, 2018. Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors. Science 360. 10.1126/science.aat4422 [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Peitz GW, Strickland JC, Pitts EG, Foley M, Tonidandel S, Smith MA, 2013. Peer influences on drug self-administration: An econometric analysis in socially housed rats. Behavioural Pharmacology 24, 114–123. 10.1097/FBP.0b013e32835f1719 [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Pellis SM, Pellis VC, 1990. Differential rates of attack, defense, and counterattack during the developmental decrease in play fighting by male and female rats. Dev Psychobiol 23, 215–231. 10.1002/dev.420230303 [DOI] [PubMed] [Google Scholar]
  139. Pellis SM, Pellis VC, 1997. The prejuvenile onset of play fighting in laboratory rats (Rattus norvegicus). Dev Psychobiol 31, 193–205. 10.1002/(SICI)1098-2302(199711)31:3<193::AID-DEV4>3.0.CO;2-N [DOI] [PubMed] [Google Scholar]
  140. Pelloux Y, Everitt BJ, Dickinson A, 2007. Compulsive drug seeking by rats under punishment: Effects of drug taking history. Psychopharmacology (Berl) 194, 127–137. 10.1007/s00213-007-0805-0 [DOI] [PubMed] [Google Scholar]
  141. Pelloux Y, Murray JE, Everitt BJ, 2015. Differential vulnerability to the punishment of cocaine related behaviours: Effects of locus of punishment, cocaine taking history and alternative reinforcer availability. Psychopharmacology (Berl) 232, 125–134. 10.1007/s00213-014-3648-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Perry AN, Westenbroek C, Becker JB, 2013. The development of a preference for cocaine over food identifies individual rats with addiction-like behaviors. PLoS One 8. 10.1371/journal.pone.0079465 [DOI] [PMC free article] [PubMed] [Google Scholar]
  143. Perry AN, Westenbroek C, Jagannathan L, Becker JB, 2015. The roles of dopamine and 1-adrenergic receptors in cocaine preferences in female and male rats. Neuropsychopharmacology 40, 2696–2704. 10.1038/npp.2015.116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Petry NM, Alessi SM, Olmstead TA, Rash CJ, Zajac K, 2017. Contingency management treatment for substance use disorders: How far has it come, and where does it need to go? Psychology of Addictive Behaviors 31, 897–906. 10.1037/adb0000287 [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Poceviciute I, Kasperaviciute K, Buisas R, Ruksenas O, Vengeliene V, 2023. Sex differences in serotonergic control of rat social behaviour. Pharmacol Biochem Behav 223. 10.1016/j.pbb.2023.173533 [DOI] [PubMed] [Google Scholar]
  146. Polcin DL, Korcha RA, Bond J, Galloway G, 2010a. Sober living houses for alcohol and drug dependence: 18-Month outcomes. J Subst Abuse Treat 38, 356–365. 10.1016/j.jsat.2010.02.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Polcin DL, Korcha RA, Bond J, Galloway G, 2010b. Eighteen-month outcomes for clients receiving combined outpatient treatment and sober living houses. J Subst Use 15, 352–366. 10.3109/14659890903531279 [DOI] [PMC free article] [PubMed] [Google Scholar]
  148. Proskynitopoulos PJ, Bleich S, Muschler MAN, Buchholz V, Frieling H, Glahn A, Rhein M, 2024. Methylation of the Oxytocin, Oxytocin Receptor, and Vasopressin Gene Promoters in Tobacco Use Disorder during Cessation. Neuropsychobiology 83, 28–40. 10.1159/000535663 [DOI] [PMC free article] [PubMed] [Google Scholar]
  149. Rachlin H, 1997. Four teleological theories of addiction. Psychon Bull Rev 4, 462–473. [Google Scholar]
  150. Rada P, Avena NM, Hoebel BG, 2005. Daily bingeing on sugar repeatedly releases dopamine in the accumbens shell. Neuroscience 134, 737–744. 10.1016/j.neuroscience.2005.04.043 [DOI] [PubMed] [Google Scholar]
  151. Rappeneau V, Castillo Díaz F, 2024. Convergence of oxytocin and dopamine signalling in neuronal circuits: Insights into the neurobiology of social interactions across species. Neurosci Biobehav Rev. 10.1016/j.neubiorev.2024.105675 [DOI] [PubMed] [Google Scholar]
  152. Rastogi K, Weerts EM, Ellis JD, 2024. Oxytocin as a treatment for alcohol use disorder and heavy drinking: A narrative review. Exp Clin Psychopharmacol. 10.1037/pha0000741 [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Rigney N, de Vries GJ, Petrulis A, Young LJ, 2022. Oxytocin, vasopressin, and social behavior: From neural circuits to clinical opportunities. Endocrinology 163. 10.1210/endocr/bqac111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. Robinson AM, Fronk GE, Zhang H, Tonidandel S, Smith MA, 2017. The effects of social contact on cocaine intake in female rats. Drug Alcohol Depend 177, 48–53. 10.1016/j.drugalcdep.2017.03.027 [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Rolls ET, Rolls BJ, Kelly PH, Shaw SG, Wood RJ, Dale R, 1974. The relative attenuation of self-stimulation, eating and drinking produced by dopamine-receptor blockade. Psychopharmacologia 38, 219–230. 10.1007/BF00421374 [DOI] [PubMed] [Google Scholar]
  156. Rossman SB, Roman JK, Zweig JM, Rempel M, 2011. The Multi-site Adult Drug Court Evaluation: The Impact of Drug Courts. Washington, DC: Justice Policy Center, Urban Institute. [Google Scholar]
  157. Sanna F, Argiolas A, Melis MR, 2012. Oxytocin-induced yawning: Sites of action in the brain and interaction with mesolimbic/mesocortical and incertohypothalamic dopaminergic neurons in male rats. Horm Behav 62, 505–514. 10.1016/j.yhbeh.2012.08.010 [DOI] [PubMed] [Google Scholar]
  158. Schmidt HD, Mietlicki-Baase EG, Ige KY, Maurer JJ, Reiner DJ, Zimmer DJ, Van Nest DS, Guercio LA, Wimmer ME, Olivos DR, De Jonghe BC, Hayes MR, 2016. Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine. Neuropsychopharmacology 41, 1917–1928. 10.1038/npp.2015.362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Schultz W, 1988. Predictive reward signal of dopamine neurons. J Neurophysiol 80, 1–27. [DOI] [PubMed] [Google Scholar]
  160. Schultz W, 2016. Dopamine reward prediction error coding. Dialogues Clin Neurosci 18, 23–32. 10.31887/DCNS.2016.18.1/wschultz [DOI] [PMC free article] [PubMed] [Google Scholar]
  161. Sharp JL, Smith MA, 2022. The effects of drugs on behavior maintained by social contact: Role of monoamines in social reinforcement. Front Behav Neurosci 15. 10.3389/fnbeh.2021.805139 [DOI] [PMC free article] [PubMed] [Google Scholar]
  162. Shin JH, Kim D, Jung MW, 2018. Differential coding of reward and movement information in the dorsomedial striatal direct and indirect pathways. Nat Commun 9. 10.1038/s41467-017-02817-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  163. Sidman M, 1953. Avoidance conditioning with brief shock and no exteroceptive warning signal. Science 118, 157–158. [DOI] [PubMed] [Google Scholar]
  164. Simons-Morton B, 2007. Social influences on adolescent substance use. Am J Health Behav 31, 672–84. [DOI] [PubMed] [Google Scholar]
  165. Skinner BF, 1938. The behavior of organisms: An experimental analysis . Appleton-Century-Crofts, New York. [Google Scholar]
  166. Skinner BF, 1953. Science and Human Behavior . Simon & Schuster. [Google Scholar]
  167. Smith MA, 2012. Peer influences on drug self-administration: Social facilitation and social inhibition of cocaine intake in male rats. Psychopharmacology (Berl) 224, 81–90. 10.1007/s00213-012-2737-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  168. Smith MA, Camp JD, Johansen AN, Strickland JC, 2023a. Response-contingent cocaine increases the reinforcing effectiveness of social contact. Exp Clin Psychopharmacol. 10.1037/pha0000679 [DOI] [PMC free article] [PubMed] [Google Scholar]
  169. Smith MA, Cha HSH, Sharp JL, Strickland JC, 2023b. Demand and cross-price elasticity of cocaine and social contact in a free-operant procedure of nonexclusive choice. Pharmacol Biochem Behav 222. 10.1016/j.pbb.2022.173511 [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Smith MA, Gergans SR, Iordanou JC, Lyle MA, 2008. Chronic exercise increases sensitivity to the conditioned rewarding effects of cocaine. Pharmacol Rep 60, 561–565. [PMC free article] [PubMed] [Google Scholar]
  171. Sofuoglu M, Dudish-Poulsen S, Nelson D, Pentel PR, Hatsukami DK, 1999. Sex and Menstrual Cycle Differences in the Subjective Effects From Smoked Cocaine in Humans, Experimental and Clinical Psychopharmacology. [DOI] [PubMed] [Google Scholar]
  172. Solié C, Girard B, Righetti B, Tapparel M, Bellone C, 2022. VTA dopamine neuron activity encodes social interaction and promotes reinforcement learning through social prediction error. Nat Neurosci 25, 86–97. 10.1038/s41593-021-00972-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Solinas M, Chauvet C, Thiriet N, El Rawas R, Jaber M, 2008. Reversal of cocaine addiction by environmental enrichment. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Song Z, Borland JM, Larkin TE, O’Malley M, Albers HE, 2016. Activation of oxytocin receptors, but not arginine-vasopressin (AVP) receptors, in the ventral tegmental area of male Syrian hamsters is essential for the reward-like properties of social interactions. Psychoneuroendocrinology 74, 164–172. 10.1016/j.psyneuen.2016.09.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Sørensen G, Reddy IA, Weikop P, Graham DL, Stanwood GD, Wortwein G, Galli A, Fink-Jensen A, 2015. The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice. Physiol Behav 149, 262–268. 10.1016/j.physbeh.2015.06.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Souza MS, Sanvicente-Vieira B, Zaparte A, Baptista T, Nagai MA, Mangone FR, Pavanelli AC, Viola TW, Grassi-Oliveira R, 2023. Cocaine use disorder effects on blood oxytocin levels and OXTR DNA methylation. Neurosci Lett 816. 10.1016/j.neulet.2023.137506 [DOI] [PubMed] [Google Scholar]
  177. Stelly CE, Haug GC, Fonzi KM, Garcia MA, Tritley SC, Magnon AP, Ramos MAP, Wanat MJ, 2019. Pattern of dopamine signaling during aversive events predicts active avoidance learning. Proc Natl Acad Sci U S A 116, 13641–13650. 10.1073/pnas.1904249116 [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Stoops WW, Lile JA, Glaser PEA, Hays LR, Rush CR, 2012. Alternative reinforcer response cost impacts cocaine choice in humans. Prog Neuropsychopharmacol Biol Psychiatry 36, 189–193. 10.1016/j.pnpbp.2011.10.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Stoops WW, Lile JA, Rush CR, 2010. Monetary alternative reinforcers more effectively decrease intranasal cocaine choice than food alternative reinforcers. Pharmacol Biochem Behav 95, 187–191. 10.1016/j.pbb.2010.01.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  180. Strickland JC, Smith MA, 2014. The effects of social contact on drug use: Behavioral mechanisms controlling drug intake. Exp Clin Psychopharmacol 22, 23–34. 10.1037/a0034669 [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Thanos PK, Tucci A, Stamos J, Robison L, Wang GJ, Anderson BJ, Volkow ND, 2010. Chronic forced exercise during adolescence decreases cocaine conditioned place preference in Lewis rats. Behavioural Brain Research 215, 77–82. 10.1016/j.bbr.2010.06.033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Thiel KJ, Okun AC, Neisewander JL, 2008. Social reward-conditioned place preference: A model revealing an interaction between cocaine and social context rewards in rats. Drug Alcohol Depend 96, 202–212. 10.1016/j.drugalcdep.2008.02.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  183. Thomsen M, Barrett AC, Butler P, Negus SS, Caine SB, 2017. Effects of acute and chronic treatments with dopamine D2 and D3 receptor ligands on cocaine versus food choice in rats. Journal of Pharmacology and Experimental Therapeutics 362, 161–176. 10.1124/jpet.117.241141 [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Thomsen M, Fink-Jensen A, Woldbye DPD, Wörtwein G, Sager TN, Holm R, Pepe LM, Barak Caine S, 2008. Effects of acute and chronic aripiprazole treatment on choice between cocaine self-administration and food under a concurrent schedule of reinforcement in rats. Psychopharmacology (Berl) 201, 43–53. 10.1007/s00213-008-1245-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  185. Thomsen M, Fulton BS, Caine SB, 2014. Acute and chronic effects of the M1/M4-preferring muscarinic agonist xanomeline on cocaine vs. food choice in rats. Psychopharmacology (Berl) 231, 469–479. 10.1007/s00213-013-3256-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Thor DH, Holloway WR, Johnstone JER, 1985. Developmental analyses of social play behavior in juvenile rats. Bull Psychon Soc 1984, 587–590. [Google Scholar]
  187. Townsend AE, Schwienteck KL, Robinson HL, Lawson ST, Banks ML, 2021. A drug-vs-food choice self-administration procedure in rats to investigate pharmacological and environmental mechanisms of substance use disorders. J Neurosci Methods 354, 109110. 10.1016/j.jneumeth.2021.109110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  188. Trezza V, Damsteegt R, Vanderschuren LJMJ, 2009. Conditioned place preference induced by social play behavior: Parametrics, extinction, reinstatement and disruption by methylphenidate. European Neuropsychopharmacology 19, 659–669. 10.1016/j.euroneuro.2009.03.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Vanderschuren LJ, Everitt BJ, 2004. Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305, 1017–1019. 10.1126/science.1098975 [DOI] [PubMed] [Google Scholar]
  190. Varlinskaya EI, Spear LP, 2008. Social interactions in adolescent and adult Sprague-Dawley rats: Impact of social deprivation and test context familiarity. Behavioural Brain Research 188, 398–405. 10.1016/j.bbr.2007.11.024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Venniro M, Panlilio LV, Epstein DH, Shaham Y, 2021. The protective effect of operant social reward on cocaine self-administration, choice, and relapse is dependent on delay and effort for the social reward. Neuropsychopharmacology 46, 2350–2357. 10.1038/s41386-021-01148-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  192. Venniro M, Zhang M, Caprioli D, Hoots JK, Golden SA, Heins C, Morales M, Epstein DH, Shaham Y, 2018. Volitional social interaction prevents drug addiction in rat models. Nat Neurosci 21, 1520–1529. 10.1038/s41593-018-0246-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Vervliet B, Indekeu E, 2015. Low-cost avoidance behaviors are resistant to fear extinction in humans. Front Behav Neurosci 9. 10.3389/fnbeh.2015.00351 [DOI] [PMC free article] [PubMed] [Google Scholar]
  194. Wilson JL, Bandyopadhyay S, Yang H, Cerulli C, Morse DS, 2018. Identifying Predictors of Substance Use and Recidivism Outcome Trajectories Among Drug Treatment Court Clients. Crim Justice Behav 45, 447–467. 10.1177/0093854817737806 [DOI] [PMC free article] [PubMed] [Google Scholar]
  195. Wise RA, 2006. Role of brain dopamine in food reward and reinforcement. Phil. Trans. R. Soc. B 361, 1149–1158. 10.1098/rstb.2006.1854 [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Wise RA, Raptis L, 1986. Effects of naloxone and pimozide on initiation and maintenance measures of free feeding. Brain Res 368, 62–68. [DOI] [PubMed] [Google Scholar]
  197. Wise RA, Schwartz HV, 1981. Pimozide attenuates acquisition of lever-pressing for food in rats. Pharmacol Biochem Behav 15, 655–656. [DOI] [PubMed] [Google Scholar]
  198. Woolverton WL, Freeman KB, Myerson J, Green L, 2012. Suppression of cocaine self-administration in monkeys: Effects of delayed punishment. Psychopharmacology (Berl) 220, 509–517. 10.1007/s00213-011-2501-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Xiao L, Priest MF, Nasenbeny J, Lu T, Kozorovitskiy Y, 2017. Biased oxytocinergic modulation of midbrain dopamine systems. Neuron 95, 368–384. 10.1016/j.neuron.2017.06.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  200. Xiao X, Deng H, Furlan A, Yang T, Zhang X, Hwang GR, Tucciarone J, Wu P, He M, Palaniswamy R, Ramakrishnan C, Ritola K, Hantman A, Deisseroth K, Osten P, Huang ZJ, Li B, 2020. A genetically defined compartmentalized striatal direct pathway for negative reinforcement. Cell 183, 211–227. 10.1016/j.cell.2020.08.032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  201. Yang T, Yu K, Zhang X, Xiao X, Chen X, Fu Y, Li B, 2023. Plastic and stimulus-specific coding of salient events in the central amygdala. Nature 616, 510–519. 10.1038/s41586-023-05910-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  202. Zamarripa CA, Doyle WS, Freeman KB, Rowlett JK, Huskinson SL, 2022. Choice Between Food and Cocaine Reinforcers Under Fixed and Variable Schedules in Female and Male Rhesus Monkeys. Exp Clin Psychopharmacol 31, 204–218. 10.1037/pha0000547 [DOI] [PMC free article] [PubMed] [Google Scholar]
  203. Zlebnik NE, Anker JJ, Carroll ME, 2012. Exercise to reduce the escalation of cocaine self-administration in adolescent and adult rats. Psychopharmacology (Berl) 224, 387–400. 10.1007/s00213-012-2760-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES